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Abstract

Specificity Determinants of ArmA, a Ribosomal RNA Methyltransferase, that confers
antibiotic resistance
By Tamara Zarubica
A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University

Virginia Commonwealth University, 2010
Major Directors: Dr. H. Tonie Wright
Professor, Department of Biochemistry and Molecular Biology
And
Dr. Jason P. Rife
Associate Professor, Department of Physiology and Biophysics

Bacterial resistance to 4,6-type aminoglycoside antibiotics, which target the 30S
ribosomal subunit, has been traced to the arm/rmt family of rRNA methyltransferases.
These plasmid-encoded enzymes transfer a methyl group from S-adenosylmethionine to
N7 of the buried G1405 in the aminoglycoside binding site of 16S rRNA in the 30S
ribosomal subunit. Neither 16S rRNA alone nor intact 70S ribosome is an efficient
substrate for armA methyltransferase. To more fully characterize this family of enzymes,
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we have investigated the substrate requirements of ArmA. We determined the Mg2+
dependence of ArmA activity and found that the enzyme could recognize both
translationally active and translationally inactive forms of 30S subunits.
To identify the site of interaction between ArmA and the 30S subunit, we used
hydroxyl radical cleavage of 16S rRNA mediated by ferrous iron chelated to several sites
on the ArmA molecule that were mutated to cysteine. This data suggests that significant
conformational changes in 30S structure are involved in binding of ArmA. We
hypothesized that a precursor intermediate in the biogenesis of the 30S subunit might be
the optimal substrate for ArmA enzymes in vivo. To test this, we prepared 30S particles
partially depleted of proteins by treatment with increasing concentrations of LiCl and
assayed them for ArmA methylation. Even low concentrations of LiCl alter the 30S
particles and greatly diminish their susceptibility to methylation. Additionally, a previously
identified pre-30S particle isolated from an E. coli culture was assayed for its ability to
support methylation by ArmA and found to be inferior to intact 30S particles as a
methylation substrate.
Thus, testing of immature particles prepared from in vitro and in vivo sources
suggest that ArmA works very late in the 30S biogenesis pathway. Initiation factor 3
(IF3), a factor that only binds fully mature 30S particles, does not inhibit the ArmA
methylation, while kasugamycin methyltransferase (KsgA) abolishes ArmA activity by
sharing the same binding site with ArmA. From aforementioned experiments, we conclude
that ArmA is most active toward 30S ribosomal subunits that are at or very near full
maturation.

Introduction

Ribosome Assembly
Ribosomes are complex and dynamic ribonucleoprotein assemblies which provide
the framework for protein biosynthesis in all organisms. Prokaryotic ribosomes consist of
two unequal sized subunits; a large 50S subunit and a small 30S subunit. The 'S' refers to
Svedberg units of the sedimentation coefficient, which measures how fast cell organelles
sediment in an ultracentrifuge. The larger or more spherical the structure, the higher its
sedimentation coefficient. Sedimentation coefficients are not additive, so that the 30S and
50S subunits of an assembled ribosome have a sedimentation coefficient of 70S and not
80S. All ribosomes share the same general architecture, with small and large ribosomal
subunits composed of rRNA (~65%) and ribosomal proteins (~35%). In E. coli, the
smaller 30S subunit is composed of the 16S rRNA and 21 proteins, while the larger 50S
subunit contains 23S and 5S rRNAs along with 33 proteins1. Ribosome biogenesis, the
process by which ribosomes are synthesized, is very complex and involves transcription of
rRNA, pre-rRNA processing, ordered binding of ribosomal proteins and metal ions,
modification of both rRNA and ribosomal proteins, and sequential conformational
changes1. Furthermore, all of these events have to be tightly regulated and coordinated to
avoid energy losses and imbalances in the cell.
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Atomic insights into structural and functional characteristics of ribosomes were
gained from the high-resolution crystal structures of individual subunits: the small subunit
from the eubacterium Thermus thermophilus 2,3 and the large subunit from the archaeon
Haloarcula marismortui 4 and eubacterium Deinococcus radiodurans5. These structures
were followed by that of the 70S ribosome from T. thermophilus6 and E. coli 7. The
structure of T. thermophilus 70S ribosome in complex with release factors RF1 and RF2
revealed details of interactions of the factors with the ribosome and mRNA8. In addition,
Selmer et al. solved the structure of T. thermophilus 70S ribosome in complex with tRNA
and mRNA9. All of these structures provide insights into the universal mechanism of
translation and complex organization of rRNA, ribosomal proteins and ligands. In addition
to crystal structures, cryo-electron microscopy studies revealed the flexibility of particles
during translation10.
Even though ribosome biogenesis represents one of the fundamental processes in
the cell, our understanding of this complex machinery is still somewhat limited. For many
decades the structural and functional studies of bacterial ribosomes has been intensively
studied. The earliest achievements in ribosome study demonstrated that functional
ribosomal subunits could be reconstituted in vitro using only the component rRNAs and
ribosomal proteins11,12. Following this discovery, 30S subunits were reconstituted using
either natural or recombinant proteins13,14 and in vitro transcribed 16S rRNA, which lacked
modifications15. Particles reconstituted from the recombinant proteins sediment as 30S
subunits in a sucrose gradient; however, they are less active in tRNA binding and 50S
ribosomal subunit association than naturally purified ribosomes12,14.
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Multiple experiments reveal that 30S subunit assembly is highly cooperative and
that ribosomal proteins assemble onto the pre-16S rRNA in a cooperative manner, with
early binding events organizing the binding sites of late proteins1. The small subunit
ribosomal proteins have been divided into three groups called primary (1o), secondary (2o),
and tertiary (3o) binding proteins. Reconstitution experiments have demonstrated that
assembly proceeds with 5' to 3' polarity, which coincides with co-transcriptional protein
binding16, as shown to occur in in vivo ribosomal assembly17 (Figure 1a). This indicates
that the body (5' region) assembles first, followed by platform (central region), and lastly
the head (3' major region). The final two helices, helix 44 and helix 45, referred to as the 3'
minor region, assemble along the body and platform regions (Figure 1b).
Both in vitro and in vivo studies have tried to analyze the pathway of ribosomal
subunit biosynthesis by identifying reconstitution intermediates. Using the in vitro
reconstitution system with 16S rRNA and total proteins from 30S subunits (TP30), it was
determined that at low temperatures (0oC to 15oC) a particle that sediments as 21S is
formed; this particle was termed RI, or Reconstitution Intermediate17,18 (Figure 2). The
components of RI are the 16S rRNA and ribosomal proteins: S4-S9, S11-S13, and S15S20. Unimolecular conformational rearrangement in the folding of 16S rRNA yields RI*,
which is a more compact particle of identical composition to RI, with a sedimentation
coefficient of 26S. The RI to RI* transition is the rate-limiting step in assembly and
requires either heat (42°) or the presence of the DnaK chaperone system19. Once this
barrier is overcome, remaining ribosomal proteins (S1-S3, S10, S14, and S21) readily
assemble, even at low temperatures, leading to formation of 30S subunits17,20.
Ribonucleoparticles similar to RI have been observed in vivo, suggesting that the above
3

described in vitro assembly process is valid21,22. There are, however, alternative assembly
pathways observed in vivo. Bubunenko et al. studied the dependence of the in vivo
assembly pathway for the 30S platform on the ribosomal protein S15, by a deletion of the
gene for S1523. The proteins S6, S11, S18, and S21, which according to the in vitro
assembly map are dependent on S15 (Figure 1a), were found in normal amounts in purified
subunits.
Although the bacterial 30S subunit can be assembled in vitro from its rRNA and rprotein components11,14, this process requires nonphysiological conditions, such as high
magnesium and monovalent cation concentration11. In vivo, however, maturation of rRNA
and assembly of the r-proteins into a functional ribosome is a highly complex process24
involving multiple accessory proteins25. In the case of the 30S ribosome subunit, a group
of proteins is necessary for the proper processing of the pre-16S rRNA. Apart from the
nucleases, which are responsible for rRNA cleavage, the in vivo assembly requires the
presence of the small GTPases Era and RsgA, as well as maturation factors RbfA, RimM,
and RimN1. The absence of these proteins results in the accumulation of 17S, a precursor
of mature 16S rRNA, which is the product of the RNase III cleavage reaction. While Era
and RimN are both essential, RimM, RbfA, and RsgA are not essential, at least under
optimal conditions26-28.
In E. coli, both tRNA and rRNA (except for the 5S rRNA) are covalently modified
during maturation, including both base and ribose modification1. The most common
modification in rRNA is base methylation, with few other modifications, including the
isomerization of uridine to pseudouridine.

4

Figure 1. Assembly of the 30S Subunit. (A) In vitro assembly map of the 30S subunit. The
primary, secondary and tertiary binding proteins are colored black, red and green,
respectively. S6 and S18 bind as a heterodimer20. (B) Domains of the 30S subunit: 5'
(blue), central (yellow), 3' major (purple) and 3' minor (red). The structure is adopted from
the E. coli crystal structure7 and modeled with PyMol29 (www.pymol.org).
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Figure 2. Prokaryotic ribosome assembly. Structures were modeled using PyMol29
(www.pymol.org)

6

The 16S rRNA contains eleven modified positions, of which ten are base
methylations, one is a pseudouridine, and one is methylation on the 2'-O of the ribose
(Figure 3). Although these modifications are not essential for protein synthesis in vitro,
their localization and conservation suggest that they might be important for folding,
assembly, or stability of ribosomes in vivo30. Most of the modified nucleotides are
clustered in important functional regions, such as the tRNA binding sites, the decoding
region, and the mRNA binding area31 (Figure 4). All the methyl groups in rRNA are added
by site-specific methyltransferases, but very limited biochemical data is available
regarding their mechanism of action. Some modifications, such as m5C967 by RsmB and
m7G527 by RsmG methyltransferase, are added to the naked 16S rRNA32,33. Other
modifications are added late during maturation of 30S ribosomal subunits1. It is possible
that the site-specific methyltransferases, which require highly ordered structure and the
presence of ribosomal proteins for their activity, recognize a certain structure which is
stabilized by the proteins. Only if the correct structure is present, will modifications occur
and the assembly process proceed.
30S Ribosomal Subunit and Its Interaction With Antibiotics
Antibiotics are natural substances secreted by certain bacteria to protect themselves
from other bacteria that are competing for limited nutrients. It has been discovered that
antibiotic producer strains have evolved to protect themselves against self intoxication.
Later generation of antibiotics used to treat people today are typically derivatives of these
natural products. Aminoglycosides have been important antibiotics for treatment of serious
bacterial infections, being especially effective against aerobic Gram-negative bacteria34.

7

Figure 3. Examples of modified nucleotides in 16S rRNA. (A) Uridine. (B) Pseudouridine.
(C) Cytidine. (D) N4, 2’- O dimethylcytidine. (E) Guanosine. (F) N7 methylguanosine.
Structures were generated using ChemSketch software.
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Figure 4. Modified nucleotides during 30S ribosomal subunit maturation. Modified
nucleotides are shown as red spheres, 16S rRNA is shown in orange, ribosomal proteins
are shown in green, and helix 44 is shown in blue. Decoding region is circled in yellow.
The structure is modeled using PyMol29 (www.pymol.org)
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Since the structures of whole bacterial ribosome subunits and ribosome-antibiotic
complexes have been determined, interest in the ribosome as a target for the discovery of
the new antibiotics has increased rapidly7,35-37. These findings have determined very
precisely the discrete binding sites of several classes of antibiotics inhibiting protein
synthesis. Three dimensional structures of ribosome-antibiotic complexes reveal that the
interaction of the antibiotic is predominantly with the RNA components of the ribosome.
Aminoglycosides are among the most commonly used broad-spectrum antibiotics
to treat aerobic gram-negative infections, such as severe infections of the abdomen and
urinary track, bacteremia and endocarditis38. Common to all aminoglycosides is the
neamine core, which is composed of a six-membered cyclitol (2-deoxystreptamine)
glycosidically linked to a glucopyranosyl. Additional sugars are attached to position 5 or 6
of the 2-deoxystreptamine moiety to form compounds categorized as 4,5- or 4,6aminoglycosides. Since the amine moieties are mostly protonated under physiological
conditions, these polycationic species show a binding affinity for nucleic acids and certain
portions of RNAs, especially prokaryotic rRNA. We are studying the 4,6-aminoglycosides,
which include but are not limited to, kanamycin, tobramycin, paromomycin, gentamicin
and geneticin. These interfere with protein biosynthesis by specifically targeting the
ribosomal decoding A site (Figure 5) and inducing codon misreading and amino acid
misincorporation. The crystal structure of the highly conserved decoding site in complex
with the 4,6-aminoglycoside geneticin (Figure 6) reveals a number of drug-nucleotide
contacts, showing the important role of the A site in drug binding36,40.
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Figure 5. Secondary structure of 16S rRNA from E. coli39.Decoding- A site is shown in red
box.
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Figure 6. Interaction of geneticin with nucleotides in the A site40. Yellow dashed lines
represent hydrogen bonds between geneticin (shown in magenta) and A site residues.

12

Aminoglycosides target prokaryotic ribosomes over eukaryotic ribosomes, even
though the internal loop of A site contains universally conserved nucleotides at six of the
seven positions41. The only difference in sequence of the internal loop is at position 1408,
which is adenosine in all prokaryotic sequences, but guanosine in all eukaryotic sequences.
The A1408-A1493 base pair within the aminoglycoside binding site is critical for high
affinity of antibiotics with rRNA42,43. This base pair, along with displacement of two
adenosines, A1492 and A1493, toward the minor groove, creates a pocket for
aminoglycosides to bind. The aforementioned bases, together with G1494, are important
for tRNA binding; hence the binding of aminoglycosides to the A site in the decoding
region interferes with the accurate recognition of cognate tRNA by rRNA during
translation44.
The structural basis for aminoglycoside mode of action has also been described
from the RNA- paromomycin complex, determined by nuclear magnetic resonance
spectroscopy, which revealed local conformational changes in the prokaryotic A site of
ribosomal RNA upon drug binding45. Binding of paromomycin presumably helps to flip
out bases A1492 and A1493 (Figure 7a), which are not well ordered in the structure of the
antibiotic- free 30S subunit2 (Figure 7b). It is possible that in the absence of the drug some
energy is required to flip out A1492 and A1493, so they can contact the tRNA. Most
likely, this energy is compensated by the formation of favorable interaction with tRNA. By
binding to the decoding site, 4,6-aminoglycosides provoke a structural rearrangement of
the decoding site from a state in which it accepts the tRNA to a conformation which is
productive for peptide bond synthesis even in the absence of cognate mRNA/tRNA
complex.
13

Figure 7. The decoding A site of the 16S rRNA in the absence of paromomycin45 (A) and
in the presence of paromomycin (B). The two universally conserved residues A1492 and
A1493 are flipped out of helix 44 in the presence of the drug. Paromomycin is shown in
magenta (B). Structures were modeled using PyMol29 (www.pymol.org).
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In the clinical setting bacteria have acquired several resistance mechanisms to 4,6
disubstituted aminoglycosides, including46: (a) deactivation of aminoglycosides by Nacetylation, adenylylation or O-phosphorylation; (b) reduction of the intracellular
concentration of aminoglycosides by changes in outer membrane permeability47, decreased
inner membrane transport48, active efflux49,50, and drug trapping51,52; and (c) alteration of
the 30S ribosomal subunit target by mutation53.
A fourth resistance mechanism is autoprotective in antibiotic producing strains of
bacteria. It confers resistance against the toxicity of the bacterium's own secondary
metabolites through methylation of their ribosomes by genome-encoded
methyltransferases54. In the presence of S-adenosyl-L-methionine (SAM), posttranscriptional methylation of specific nucleobases of rRNA in the aminoglycoside binding
site of these strains blocks binding of aminoglycoside antibiotics and maintains faithful
protein synthesis. Recently, six distinct but related plasmid borne 30S rRNA
methyltransferases that confer resistance have been identified in clinical bacterial strains:
ArmA55, RmtA56, RmtB57, RmtC58, RmtD59, and RmtE60. All methylate N7 of G1405 and
thereby confer resistance to the 4,6- di-substituted aminoglycosides61,62 (Figure 8). These
six methyltransferases confer no known physiological advantage in the absence of the
antibiotics, in contrast to the many endogenous housekeeping methyltransferases that are
important for the structure and function of mature rRNA.
It has been shown that the aminoglycoside gentamicin has a high specificity for the
A site of translationally active 30S ribosomal subunits37. Using footprinting experiments, it
has been observed that the 30S subunit was unable to bind gentamicin as a result of G1405
methylation by ArmA61. The interaction of 30S subunits with gentamicin was probed by
15

Figure 8. Post transcriptional modification of G1405 by Arm/Rmt methyltransferases. The
figures were generated using ChemSketch Software.
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chemical modification by dimethylsulfate (DMS) and it was found that 30S subunits
purified from a strain carrying the armA gene were methylated at G1405. Footprinting of
m7G1405 ribosomes did not reveal protection at G1494, even at 100 mM gentamicin,
indicating that binding of the antibiotic did not occur. In addition, a mutation in the A site
hairpin (G1405C/C1496G) disrupted binding of gentamicin (4,6 disubstituted 2deoxystreptamine), but did not affect the binding of other classes of aminoglycosides, for
example paromomycin, a 4,5 disubstituted 2-deoxystreptamine61.
Arm/Rmt m7G Methyltransferases
A significantly increased spread of N7 G1405 methyltransferases among Gramnegative pathogens has been observed recently. Galimand et al. found the first gene
responsible for high-level resistance to 4,6-disubstituted deoxystreptamines and fortimicin
and named it aminoglycoside resistance methyltransferase (armA), which encodes a
putative 16S rRNA m7G methyltransferase55. Sequence analysis reveals that ArmA belong
to the ArmA family of methyltransferases, whose hosts are mainly antibiotic producers
Streptomyces and Micromonospora species, as well as pathogens (Figure 9). The overall
sequence identity between ArmA and its homologs varies between 21 and 30%, and the
levels of similarity are between 37 and 47% 55. Low guanine-plus-cytosine content of
armA (30%) distinguishes it from those of antibiotic producing strains, such as grmA
(65%) and kgmB (71%), which indicates that armA has not evolved from the resistance
gene in the actinomycetes. However, due to the absence of sequences homologous to armA
in the data banks, the question remains open as to the identity of the progenitor. The armA
gene is borne by conjugative plasmid, in which it is flanked by putative transposable

17

Figure 9. Sequence alignment of ArmA from K. pneumonia (Q7WSN7),RmtA from P.
aeruginosa (Q8GRA1), RmtB from E. coli (Q763K9), RmtC from P. mirabilis (Q33DX5),
RmtD from P. aeruginosa (A0MK31), KgmB from S. tenebrarius (Q53316), NbrB from S.
hindustanus (O52472), GrmA from M. purpurea (Q7OKC8), Sgm from M. zionensis
(Q7MOR2), and FmrO from M. olivasterospora (Q2MFZ2). Identical amino acids in all
proteins are denoted with a star. The alignment was generated using Clustal X web server.
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elements. These elements favor dissemination of armA, so it is not very surprising that the
gene is found in various members of the Enterobacteriaceae family.
The Arm/Rmt family belongs to a well-characterized group of S- Adenosyl- LMethionine (SAM) dependent methyltransferases, which includes RNA
methyltransferases, DNA methyltransferases, protein methyltransferases and small
molecule methyltransferases63. This group of enzymes contains a Rossman-like fold,
which consists of a central β sheet surrounded by a variable number of α helices, and they
share several conserved motifs64-66 (Figure 10). Many of the Rossman-like
methyltransferases have been well characterized structurally and biochemically, and their
mechanisms have been explored. In the nucleic acid methyltransferases, the target base is
flipped out of a stable conformation in secondary structure in order to be methylated. This
mechanism is found in DNA methyltransferases, whose targets reside within the double
helix. It is very likely that a similar mechanism is present in the Arm/Rmt
methyltransferases, where the N7 position of the modified base G1405 is completely
buried within helix 442,7.
Arm/Rmt methyltransferases recognize assembled 30S ribosomal subunits as their
substrates in vitro61. Despite the high degree of rRNA conservation in the region of
methylated G1405, 16S rRNA alone is not an efficient substrate for ArmA61. Although 16S
rRNA is the target molecule of about eleven enzymes, only in two cases can it serve as an
in vitro substrate. The housekeeping methyltransferases RsmB and RsmG, which
methylate m5C967 and m7G527 respectively, are enzymes that can utilize 16S rRNA as in
vitro substrates32,33. More often full or partial assembly is required before full methylation
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Figure 10. The crystal structure of truncated ArmA65 (wheat) superimposed on RmtB65
(magenta) and Sgm66 (green). Figures were generated using PyMol29 (www.pymol.org).
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can occur, suggesting that rRNA modification is integrated into ribosome assembly in vivo
by being able to recognize more complex substrates67. In some cases, 30S ribosomal
subunit in the presence of high Mg2+ concentration fails to serve as an efficient substrate,
possibly indicating that a low Mg2+ concentration induced or translationally inactive
conformation is recognized by the modification enzyme, but the high Mg2+ or
translationally active conformation is not68. Biochemical studies indicate that these two
states are structurally very similar, except in the decoding region69-71.
This dynamic decoding region corresponds to the region of 30S ribosomal subunits
that has the highest density of modified nucleotides (Figure 4). For that reason, it is not
very surprising that there is variable access to nucleotides that are to be modified. For
example, the housekeeping methyltransferase KsgA, which modifies nucleotides A1518
and A1519, requires relaxation of tertiary interactions between helix 44 and helix 45 to
methylate the bases72. Likewise, some conformational accommodations on the part of 16S
rRNA are presumably required for Arm/Rmt to methylate its target nucleotide G1405. The
structure of fully formed translationally active 30S ribosomal subunit reveals that G1405,
the target nucleotide for Arm/Rmt methyltransferases, is buried as a consequence of direct
tertiary interaction with nucleotide A1518 of the helix 452,7 (Figure 11). The sequestered
position of the Arm/Rmt target nucleotide G1405 and the heavy traffic of modifying
enzymes converging on this region, suggest that conformational rearrangement of 16S
rRNA might be required for these enzymes to access their target nucleotide. Liou et al.
showed that isolated helix 44, where G1405 lies, is not a possible substrate for ArmA61.
This indicates that Arm/Rmt methyltransferases, as well as modification reactions of 16S
rRNA during 30S ribosome assembly, are sensitive to a number of solution variables and
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.

Figure 11. Tertiary interaction between G1405 (red sphere) and A1518 (blue sphere). Both
nucleotides are circled in magenta. Black arrow points to the modified position N7 of
G1405. Insert shows the hydrogen bonds shared between the same nucleotides. Figures
were generated using PyMol29 (www.pymol.org)
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assembly states. It is very likely that efficient substrates in many ribosomal modification
reactions are often some assembly state other than 16S rRNA or 30S ribosomal subunit.

Unanswered questions
Aminoglycosides are used extensively for the treatment of severe infections caused
by Gram-negative bacteria. Recently, however, certain bacterial pathogens have developed
resistance after acquiring genes for methyltransferases that catalyze post-transcriptional
methylation of N7-G1405 in the 30S ribosomal subunit. Inactivation of this enzymatic
activity presents an important challenge and opportunity to develop effective inhibitors that
will retain the effectiveness of aminoglycoside antibiotics. For that reason, we were
interested in biochemically and structurally characterizing this group of enzymes in order
to better understand their mechanism of action. Recent studies on ArmA homologs have
opened up intriguing lines of inquiry. However, there is a lack of information about the
exact mechanism of Arm/Rmt-catalyzed reactions, which is not surprising given the short
time that this group of enzymes has been studied. One unresolved question is the order of
substrate binding: Is 30S ribosomal subunit or SAM required to bind first and create the
binding site for the second substrate?
In addition, the exact nature of Arm/Rmt’s complex substrate requirements is not
fully understood. The enzyme cannot methylate the isolated helix 44, 16S rRNA, 50S
ribosomal subunit or 70S ribosome, but the fully formed 30S ribosomal subunit is
methylated in vitro61. This indicates that Arm/Rmt requires a highly structured
ribonucleoprotein particle as its optimal substrate, where access is blocked by the 50S
ribosomal subunit. The window during ribosome biogenesis between free RNA and mature
23

30S subunit when Arm/Rmt can access nucleotide G1405 and transfer the methyl group
remains to be defined. It was shown that the late acting ribosomal methyltransferase RsmF,
which methylates m5C1407 during ribosome biogenesis, is obstructed by the presence of
Sgm, an ArmA homolog73,74. In contrast, the two methylations at 16S rRNA nucleotide
m4Cm1402 are unaffected by the presence of Sgm73,75. This indicates that Arm/Rmt acts
later during ribosome biogenesis and that interaction between housekeeping
methyltransferases and resistance methyltransferases plays an important role in Arm/Rmt
methyltransferases mode of action.

Scope and objectives
Housekeeping methyltransferases play a role in prokaryotic ribosome maturation
and are synchronized with rRNA processing, ordered binding of ribosomal proteins and
conformational changes31,74,76. In 16S rRNA, many of the base modifications are clustered
in the phylogenetically conserved and functionally essential decoding region of the 30S
subunit77. The aminoglycoside binding pocket and G1405, the target of ArmA, are located
within the A-site of the decoding region and are flanked by several methylated nucleotides:
C1402, C1407, U1498, A1518, and A1519. This tight clustering very likely imposes an
evolved order of methylation steps to avoid methyltransferase crowding and possible
obstructive stereoelectronic effects to downstream methylations introduced by the
modifications. Such constraints would require synchronization of ArmA with the other
housekeeping methyltransferases. The sequestered position of the Arm/Rmt target
nucleotide G1405 in the crystal structure of the 30S subunit and the heavy traffic of
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modifying enzymes converging on this region78, suggest that conformational
rearrangement of 16S rRNA might also be required for these enzymes to access their target
nucleotide.
Given that very limited biochemical data has been reported on the function of this
group of enzymes, this study is intended to further investigate the Arm/Rmt mechanism of
action. The substrate specificity and requirements of ArmA were investigated to both
characterize the enzyme and to resolve the conundrum of how they interact with their
target nucleobase. We determined the Mg2+ dependence of ArmA activity and the effects
of gentamycin, kasugamycin resistance methyltransferase (KsgA) and initiation factor 3
(IF3) binding to 30S subunits on ArmA activity. We also tested LiCl treated 30S particles
and in vivo derived pre-30S ribosomal subunits as ArmA methylation substrates. We find
that very late steps in 30S ribosomal maturation are prerequisites for these
methyltransferases to carry out their modification reaction, since the best substrate for
ArmA is a highly structured ribonucleoprotein particle, very close in conformation to the
fully mature 30S substrate. Conformational changes, either very late in the pathway of
30S ribosomal subunit assembly or off-pathway, appear to be necessary for Arm/Rmt
methyltransferase to access the completely buried G1405.
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Cloning, Production, and Initial Characterization of Arm/Rmt Enzymes
For proteins to be analyzed using informative structural methods such as X-ray
crystallography or NMR, they have to be highly soluble and stable over a reasonable
period of time. While sometimes proteins of interest behave in this way, more often protein
purification can be challenging and difficult. Preparation and expression of proteins can
have many obstacles, such as protein aggregation and proteolytic degradation. Protein
insolubility at higher concentration can present problems, especially if the aim of the study
is to structurally characterize the protein. In order to improve the yield of soluble protein,
many strategies are used, including the optimization of protocols for expression and
purification of proteins, or expressing the desired proteins in alternative host cells.
The purification and expression of the ribosomal methyltransferase, RmtA, was
initially undertaken for purposes of structural characterization of this group of enzymes.
Pseudomonas aeruginosa pJ31:6303- rmtA was synthesized chemically (DNA. 2.0 Inc.) to
incorporate NdeI and XhoI cleavage sites for cloning. These enzymes (New England
Biolabs) were used for digestion of the synthetic DNA and the resultant fragments were
ligated into the plasmid vector pET15b, which had been digested with these same enzymes
(NdeI and XhoI). Escherichia coli XL1-Blue (Stratagene) was transformed with the
ligation mixture and transformants were selected on Luria-Bertani agar plates
supplemented with 30 mg/ml of kanamycin.
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The pET15b-rmtA plasmid containing an N-terminal His-tag coding region was
isolated using a Qiagen Mini-prep kit. The correct ArmA sequence was confirmed by the
Nucleic Acid Research Core Facility at Virginia Commonwealth University. The plasmid
was transformed into both HMS17 and BL-21(DE3) cells for protein production, but only
the latter produced colonies. This construct gave very low RmtA expression, so other
plasmid constructs made by cloning rmtA into pET20-b, pET21-c and pET31-b, were
tested for better RmtA expression. Unfortunately, these three constructs showed even
lower expression compared to the pET15-b- rmtA, with most of the enzyme being in
inclusion bodies. Even when the enzyme was produced under conditions of lower
temperatures at 18oC/ 25oC or lower concentration of IPTG (0.1 mM), the solubility of
RmtA did not change significantly. In the end, the original pET15b N- terminal His-tag
construct yielded the most soluble protein of the three constructs, but the enzyme remained
too unstable at higher concentrations (>5 mg/ml) to be amenable to structural
characterization. Even the use of multiple solubility screens, such as different pH and salt
concentrations, failed to increase protein solubility enough to screen for crystallization.
Escherichia coli DH10B+ pJ210:10629- rmtC was also obtained from DNA 2.0
Inc. NdeI and XhoI (New England Biolabs) were used for digestion of the synthetic DNA
and the digest ligated into the plasmid vector pET29-b, which carries a C-terminal His tag
coding region. E. coli XL1-Blue (Stratagene) was transformed with the ligation mixture,
and transformants were selected on Luria-Bertani agar plates supplemented with 100
mg/ml of ampicillin and 30 mg/ml chloramphenicol. The sequence of isolated pET29brmtC plasmid was confirmed by the Nucleic Acid Research Facilities at Virginia
Commonwealth University. However, RmtC engineered with a C-terminal His-tag showed
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low in vitro methylation activity. This may be due to the His - tag affecting the correct
folding of the protein or the binding of the two substrates, 30S ribosomal subunit and S –
Adenosyl-L-Methionine (SAM). Therefore, the rmtC gene was ligated into pET15b, which
contains an N-terminal His-tag coding region. The correct rmtC sequence was confirmed
by Nucleic Acid Research Facilities at Virginia Commonwealth University. RmtC was
over-expressed with 1 mM IPTG and purified by Ni-NTA affinity chromatography.
Protein purification attempts were made more difficult by insolubility of the overexpressed
RmtC, so purification conditions were optimized for production of soluble protein. Under
different buffer conditions, RmtC was not stable in the absence of at least 10% glycerol
and reducing agent, either dithiothreitol (DTT) or β-mercaptoethanol (BME). Even under
these conditions, the protein precipitated out when stored for more than one week at 4°C.
Acinetobacter baumannii pUCarmA1-armA construct was obtained from Dr. Yohei
Doi, of the University of Pittsburgh School of Medicine. The gene encoding armA was
inserted into pET15b as an NdeI-XhoI fragment with an N-terminal His tag. The correct
ArmA sequence was confirmed by Nucleic Acid Research Core Facility at Virginia
Commonwealth University. The plasmid was transformed into BL-21(DE3) cells for
protein production. ArmA was overexpressed with 1 mM IPTG, purified by Ni-NTA
affinity chromatography eluting with 0.3M Imidazole. Protein was estimated to be >95%
pure using SDS-PAGE analysis and stable for at least a few weeks at 4oC. Since ArmA
with an N- terminal His-tag showed improved stability relative to the Rmt constructs over
a longer period of time, we decided to conduct our future experiments using this enzyme.
In vitro activity assays confirmed that the correct enzyme was purified (see below).
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In vitro Analysis
The relative enzymatic efficiency of RmtA, RmtC and ArmA in methylation of E.
coli wild type 30S ribosomal subunits in an in vitro activity assay was determined.
Substrate 30S subunits were prepared from wild type E. coli as described in the
experimental section. Incorporation of 3H-methyl from labeled SAM by each enzyme was
measured after an incubation of one hour. Negative control experiments were performed
with 30S subunits in the absence of enzymes. Also, the same assay was attempted in the
absence of 30S ribosomal subunits, but in the presence of methyltransferases. All
experiments were performed with 10 pmol of 30S substrate and 10 pmol of enzyme. In
vitro activity assays for RmtA and RmtC showed somewhat lower final incorporation of
3

H- SAM compared to ArmA (Figure 12). This might be due to the solubility problems

seen for RmtA and RmtC. It is likely that the enzymes started forming aggregates during
the in vitro assay (as was also noticed during the purification step) leaving only a fraction
of soluble RmtA/RmtC available to methylate the 30S ribosomal subunit. Another reason
for differences in incorporation of 3H-methyl from labeled SAM could be the use of
different 30S ribosomal subunit preparations. Nevertheless, it seems that ArmA is simply
more efficient than the other two enzymes.
The Arm/Rmt enzymes transfer only one methyl group from the SAM molecule to
guanosine 1405. The exact mechanism of transfer has not yet been established. Question
remains as to a preferred order, if any, of substrate binding. So, our next question was to
see if the order of substrate addition for the 30S ribosomal subunit and SAM would
influence the incorporation of 3H from the labeled SAM by ArmA (Figure 13 A). All
experiments were performed with 10 pmol of 30S substrate and 10 pmol of enzyme, and
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the data was fit using logarithmic curve. With stoichiometric amounts of protein relative to
30S, the time-course of methylation was essentially indistinguishable among the different
experiments, confirming that the order of substrate addition did not influence the final
level of methylation. In addition, the rate of incorporation of methyl group does not change
when substrates are added in a different order (Figure 13B). This result is, however, open
to interpretation. Due to the complex mechanism, it is possible that the addition of the
second substrate, but not the first one, represents the slow step in the reaction. In our
experiment, we were limited in detecting only the net chemical reaction, so additional
methods might be necessary to determine which step in the reaction is rate - limiting.
Mg+2 Dependence of ArmA Activity
It is known that the conformational state of the 30S ribosomal subunit is sensitive
to the concentration of Mg+2 and NH4Cl79,80. High Mg+2 concentrations stabilize an active
state of 30S, while low concentrations of Mg+2 stabilize a translationally inactive
conformation of the 30S subunits 69. It has been determined that ArmA is active in
methylating 30S ribosomal subunits at higher concentration of Mg+2 61. In order to further
explore the magnesium dependence of ArmA activity, we varied the concentration of this
divalent cation in our assays (Figure 14A). The broad plateau of maximal ArmA activity in
the range of 10 - 15 mM Mg+2 indicates that the enzyme methylates the translationally
active form of the 30S subunit. However, ArmA retains 1/2 of its maximal activity at 4
mM Mg+2, where the translationally inactive form of the 30S subunit predominates,
suggesting that ArmA recognizes both the translationally active and inactive forms.
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Figure 12. In vitro methylation of 30S by RmtA (A), RmtC (B), and ArmA (C). All
reactions were performed for 1 hour at 37 °C in Buffer ‘R’ and contained 3H-SAM.
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Figure 13. In vitro methylation of 30S subunit. Time-course assays for ArmA (A)
measured over 90 minutes. Blue diamond indicates assays containing 10 pmol 30S added
first, then 10 pmol enzyme, and SAM ; red square indicates assays containing 10 pmol of
enzyme added first, then SAM and 10 pmols 30S; green triangle indicates assays
containing 10 pmol 30S added first, then SAM and 10 pmols of enzyme; purple cross
indicates assays containing 10 pmol of enzyme added first, then 10 pmol 30S and SAM.
Blue star indicates assays containing SAM added first, then 10 pmol 30S and 10 pmol of
enzyme; orange circle indicates assays containing SAM added first, then 10 pmol of
enzyme and 10 pmol 30S. (B) In vitro methylation assay measured in the first 10 minutes.
The data was fit using logarithmic (A) or linear (B) curve. The same legends applied as in
the part (A).
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As a further test of whether ArmA recognizes the low Mg+2 translationally inactive
form of the 30S subunit, we utilized kasugamycin resistant (ksgR) 30S subunits, which lack
methyl groups on A1518 and A1519. On the basis of the known tertiary interaction
involving modified nucleotides A1518/A1519 with helix 44, these methylations are
expected to stabilize the active conformation of the 30S subunits and their absence should
increase the proportion of translationally inactive form in the low Mg+2 concentration
transition range2,7. The Mg+2 dependence of ArmA activity is similar for the wild type and
ksgR forms of 30S subunit at high Mg+2 concentrations: both have broad maxima centered
around 8 – 10 mM. However, the activity profile for the ksgR substrate (Fig. 14B) is
skewed to significantly higher activity at lower Mg+2 concentrations (4 - 6mM) than the
wild type. While the Mg2+-dependence of ArmA activity is somewhat sensitive to the
presence of A1518 and A1519 methylation, it is clear that ArmA is capable of recognizing
both the inactive and active forms of 30S subunits. Mathew Baker from our lab also tested
the ArmA ortholog RmtA for activity in the presence of low and high Mg+2 concentrations
and obtained similar results (data not shown).
Conclusions
Arm/Rmt enzymes identified in clinical strains post-transcriptionally methylate
nucleotide G1405 at the N7 position in the presence of SAM, and confer resistance to the
4,6-disubstituted aminoglycosides61,81. These methyltransferase enzymes provide no
known physiological advantage in the absence of the antibiotics and in that sense they
differ from many endogenous, housekeeping methyltransferases, which are important for
both the structure and function of the rRNA1.
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Figure 14. Effect of Mg2+ on Arm activity. In vitro methylation of wild-type 30S (A) and
ksgR 30S (B)
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The decoding region of E.coli 16S rRNA alone, where the modified G1405 lies,
contains several nucleotides that are methylated by endogenous methyltransferases, such as
C140275, C140774, and U149867. With all of these bulky methyltransferases operating in
this small region of 16S rRNA, it is difficult to picture another enzyme finding its way to
modify G1405. Substrate recognition by the Arm/Rmt methyltransferases might be
complex. Arm/Rmt is able to methylate 30S ribosomal subunit in vitro, but it does not
methylate either 70S ribosome or 16S rRNA61. In addition, isolated helix 44 is not an
efficient substrate for ArmA61, proving that the enzyme recognizes structured
ribonucleoprotein in vitro. The reported kcat value for ArmA61, 0.2 min-1 is comparable to
turnover numbers for RsmE67, 0.042 min-1 and RrmJ82, 0.064 min-1, indicating that ArmA,
like RsmE and RrmJ, might require highly assembled ribosomal particles for methylation.
In contrast to ArmA, RmsB and RlmD methyltransferases have significantly higher
turnovers in vitro: 2.6 min-1 and 3.6 min -1, respectively32,83. However, this is somewhat
expected, since these latter enzymes act on free rRNA and may not require highly
structured substrates. If we take into account that the time required for 30S subunit
maturation in vivo has been reported to be only a few minutes, ArmA does not act very
slowly in vivo84. It is clear from the 30S crystal structure that G1405, the target nucleotide
for Arm/Rmt methyltransferases, is buried as a consequence of direct tertiary interactions
with nucleotides A1518 and A1519 of helix 457. It has not been confirmed if there is an
obligate order to substrate binding to allow ArmA to access the buried nucleotide. Enzyme
binding to 30S subunits most likely requires either conformational rearrangement of 16S
rRNA or the substrate that we use for an in vitro study is different in some way from the
one that is modified during ribosome assembly in vivo. Our results demonstrate that ArmA
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is able to methylate both active and inactive conformations of 30S ribosomal subunits in
vitro, and that the order of substrate addition does not influence the final level of
methylation. However, the complexity of the Arm/Rmt methyltransferases imposes the
need to further explore and understand their mechanism of action.
Experimental
Cloning
A synthetic rmtA gene was obtained from DNA 2.0. The 776 base-pair rmtA gene
was amplified by PCR using the following primers, purchased from Integrated DNA
Technologies: 5’-CTG ACT GCA ATA TGA GCT TTG ACG ATG CCC-3’ and
5’- CTG CCT CGA GTC ACT TAT TCC TTT TTA TCA TGT ACA C-3’. The gene was
cloned into the pET15b vector (Novagen) as an NdeI/XhoI fragment for expression as an N
terminal His tagged fusion construct. The recombinant plasmid was sequenced (Nucleic
Acids Research Facilities, VCU) to confirm the presence and correct sequence of the
insert.
A synthetic rmtC gene was obtained from DNA 2.0. The 879 base-pair rmtC gene
was amplified by PCR using the following primers, purchased from Integrated DNA
Technologies: 5’- ATA CAT ATG AAA ACC AAC GAT AAT TAT ATC GAA -3’ and
5’- ATA CTC GAG TCA CAA TCT CGA TAC GAT AAA ATA CAT-3’. The gene was
cloned into pET15b vector (Novagen) as an NdeI/XhoI fragment for expression as a His
tagged fusion construct. The correct clone was confirmed by sequencing (Nucleic Acids
Research Facilities, Virginia Commonwealth University).
Acinetobacter baumannii pUCarmA1-ArmA construct was obtained from Dr.
Yohei Doi, from the University of Pittsburgh School of Medicine and was confirmed by
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sequencing. The gene encoding armA was inserted into pET15b as an NdeI-XhoI
fragment. The isolated pET15b-armA plasmid contained N-terminal His-tag coding region.
The correct ArmA sequence was confirmed by the Nucleic Acid Research Facilities at
Virginia Commonwealth University.
Protein expression and purification
pET15b-RmtA and pET15b-RmtC plasmids were transformed into BL-21 (DE3)
Rosetta II cells for overexpression. Cell cultures were grown to an OD600 of 0.6 in the
presence of ampicillin and chloramphenicol and induced with 1 mM IPTG (SigmaAldrich). After 4 hours at 37ºC, cells were harvested by centrifugation. Pellets were
resuspended in lysis buffer (50 mM NaPO4, 500 mM NaCl, 10 mM imidazole, 10 %
glycerol, 1 mM DTE pH 7.5), broken with two passages through an Emulsiflex cell
breaker (Avestin), and centrifuged to remove cell debris. Cleared lysate was loaded onto a
HiTrap Chelating column (Amersham) equilibrated with 0.1M NiSO4, washed with lysis
buffer and the proteins were eluted with elution buffer (50 mM NaPO4, 500 mM NaCl,
300 mM imidazole, 10% glycerol, 1 mM DTE pH 8.0).
The pET15b-ArmA plasmid was expressed in BL21 (DE3) cells (Stratagene). The
cells were grown at 37ºC to an OD600 of 0.6 in the presence of ampicillin. The protein
was induced with 1 mM IPTG and transferred to 37ºC for 4 hours. Cells were harvested
and broken as for RmtA and RmtC. Purification was carried out by affinity
chromatography using a Ni-NTA chromatography column; buffers were the same as
above. Proteins were estimated to be >95% pure by SDS-PAGE analysis. Protein
concentration was measured using the absorbance at 280 nm and the extinction coefficient,
using protein calculator v3.3, for each protein. (http://www.scripps.edu)
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30S purification
For in vitro activity assay, 30S ribosomal subunits from the MRE600 strain of E.
coli were prepared as described85. For 30S subunits lacking methylation at A1518 and
A1519, an MRE600 strain resistant to the antibiotic kasugamycin were used86. Subunits
from this strain are referred as 30S-ksgR.
Wild-type purified subunits were dialyzed into reaction buffer (40 mM Tris, pH
7.4; 40 mM NH4Cl; 8 mM MgOAc; 1 mM DTE) and stored at –80ºC in single-use
aliquots. The ksgR purified subunits were dialyzed into reaction buffer (40 mM Tris, pH
7.4; 40 mM NH4Cl; 4 mM MgOAc; 1 mM DTE) and stored at –80ºC in single-use
aliquots. 30S concentration was estimated by measuring the absorbance at 260 nm and
using a relationship of 67 pmol 30S per 1 unit of optical density.
In vitro analysis
The in vitro assay was adapted from Poldermans et al. (1979). Time-course reactions were
performed in 50 µl volumes containing 40 mM Tris, pH 7.2, 40 mM NH4Cl, 8 mM
MgOAc, 1 mM DTE, 0.02 mM 3H-methyl-SAM (780 cpm/pmol; MP Biomedicals), 10
pmol 30S subunits, and 10 pmol enzyme. Buffer and reagents were pre-warmed to 37ºC
and added into pre-warmed tubes to minimize any lag in the reaction start. At each of the
designated time points 10 µl of 100 mM unlabeled SAM (Sigma- Aldrich) was added to
tubes to quench the reaction. The quenched reactions were deposited onto DE81 filter
paper (Whatman), washed twice with ice-cold 5% TCA, and rinsed briefly with ethanol.
Filters were air-dried for one hour, placed into scintillation fluid, and counted.
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ArmA Interaction With its Substrates - 30S subunit and
S-Adenosyl-L-Methionine
Introduction
The interaction between ArmA and 30S subunit is complex and details of the
mechanism of ArmA action are not known, in part because of the limited biochemical data
on this group of enzymes. Neither 16S rRNA alone nor 70S ribosome is a substrate for
Arm/Rmt methyltransferases, while assembled 30S subunit is methylated by purified
ArmA in vitro 61. If we examine the crystal structure of fully formed translationally active
30S subunits, we notice that the target nucleotide G1405 is sequestered from the surface
and is inaccessible for modification by ArmA 2,7 (Figure 15). However, Agarwal et al,
using cryo-electron microscopy revealed that the 30S subunit is conformationally flexible,
with the conformational changes mainly localized in the neck, the platform and shoulder
regions10. Since the ArmA target nucleotide lies in helix 44, a highly flexible region of
30S, the enzyme presumably induces a conformational change required for the methylation
of G1405. It is also possible that the mechanism of ArmA action includes the flipping out
of the modified base G1405. Base flipping has been documented for both DNA- and RNAmodifying enzymes and is believed to be the dominant mechanism used by these enzymes
to access target bases that are normally inaccessible due to secondary and/or tertiary
interactions in the nucleic-acid molecule87.
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Figure 15. Modified nucleotide G1405 (circled in red) in the 30S ribosomal subunit. The
16SrRNA is shown in orange and the ribosomal proteins are shown in grey. The red arrow
points toward the buried N7 position of G1405. Structures were generated using PyMol29.
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To gain a better understanding of the complex mode of ArmA action, we undertook
investigation of the ArmA interaction with the 30S ribosomal subunit. Directed hydroxyl
radical probing, followed by primer extension analysis, was used to investigate ArmA
interaction with its substrate 30S ribosomal subunit88,89. Directed hydroxyl radical probing
generates low resolution (10–50 Å) information about the part of a nucleic acid that is in
the vicinity of a defined site on a protein or other nucleic acid90. This approach has been
used to study the 16S rRNA environment around individual ribosomal proteins in the 30S
subunit88,91, elongation factors92, initiation factors93, release factors94, ribosome recycle
factors 95, and ribosomal methyltransferases72. This approach was used to explore the sites
of interaction between ArmA and 30S subunit to determine the specific contact regions
between the two.

Results
Directed Hydroxyl Radical Probing
To probe 16S rRNA with hydroxyl radicals, Fe(II) is tethered to specific positions
on the surface of a protein by reaction of the Fe(II)-loaded linker, 1-(pbromoacetamidobenzyl)-EDTA96,97 with unique cysteine residues. To produce ArmA with
different unique single cysteine residues, the only naturally found cysteine in ArmA at
position C115 was mutated to alanine. This mutant with no cysteine (cys-less) was used as
our control sample and served as background when comparing the other cleavage sites on
the primer extension gel. The cys-less mutant was used to construct double mutants and to
insert single cysteine residues at positions 43, 59, 64, 190, 220, and 234 (Y43C, Y59C,
L65C, V190C, M220, G234C). These positions on ArmA are shown in Figure 16.
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Figure 16. ArmA cysteine mutants. Backbone atoms of residues which were mutated to
cysteine are shown as spheres. Y59C is yellow, L65C is orange, C115 (wild type) is cyan,
V190C is blue, and G234C is magenta. Y43C is not shown in the figure since the N
terminal truncated form of ArmA58 was used. The structure was generated using PyMol29.
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We chose these specific residues based on several criteria. First, we wanted to
mutate residues that were not conserved in ArmA, thus limiting the likelihood that they
would interfere with protein folding and function. Second, we wanted to mutate residues
that are surface exposed and readily accessible to solvent. Lastly, we chose residues that
were widely spaced throughout ArmA, so that the information we gained from the
hydroxyl radical experiment would not be redundant. Before starting the experiment, we
checked in vitro methylation activity of each mutant and found that all except one, ArmA
C115A M220C, could fully methylate 30S subunit (Figure 17). We discontinued working
with this ArmA double mutant, since it precipitated out during purification steps. The six
selected mutants were purified as previously described in Chapter 2.
In this technique, hydroxyl radicals are generated locally from Fe(II) tethered to a
single position in ArmA, resulting in cleavage of the rRNA backbone at positions
proximal to the Fe(II) ion. Because of the short lifetime of hydroxyl radicals in aqueous
solution, cleavage is usually restricted to positions in the RNA that are within about 10 Å
of the Fe(II) ion88. Fe(II) is tethered to the unique cysteine residue at specific sites in
ArmA via 1(p-bromoacetamidobenzyl) -EDTA (BABE), a reagent that has been
successfully used to map intramolecular distances in proteins98. Iron-derivatized ArmA is
incubated with a fully formed 30S subunit to create a complex (Figure 18). Once the
complex between ArmA and 30S subunit is formed, hydroxyl radicals are generated by the
Fenton reaction in the presence of H2O2 and ascorbic acid 99. After cleavage the RNA is
extracted from the 30S subunits, annealed with labeled primers, and analyzed by primer
extension, an extremely sensitive technique for detecting breaks in the RNA backbone
(Figure 19).
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Figure 17. In vitro activity assay of ArmA cysteine mutants.
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Figure 18. Site directed hydroxyl radical probing. Single cysteine residues (shown as
yellow spheres) are mapped onto the ArmA structure (A). Fe(II)- BABE is attached to each
single cysteine residue, represented as a black star (B). ArmA single cysteine residues are
incubated with 30S subunit to form a complex (C). In the presence of H2O2 and Ascorbic
acid, hydroxyl radicals are generated to cleave 16S rRNA backbone (D).
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Figure 19. Primer extension. Cleaved 16S rRNA is first annealed with radio labeled
primers and then extended using reverse transciptase in the presence of free nucleotides.
The product is analyzed on sequencing gel as shown in Figure 20.
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In this work, synthetic DNA oligomers were used to anneal to target RNA template
sequence and prime DNA polymerization by reverse transcriptase. These primers were
generally 17 nucleotides long and were complementary to a single region of the target
16S RNA. Cleavages of the RNA were indicated by the appearance of additional bands,
above background, in the autoradiogram, which represent abortive cDNA transcripts
ending at the position of RNA template cleavage. Portions of the RNA backbone which are
in proximity to the Fe(II) will be cleaved more often than positions which are further away.
Therefore, more cleavage events occurring at a particular site correspond to a heavier band
on the gel. Figure 20 shows representative autoradiograms, which include two dideoxy
sequencing lanes, a control cys-less ArmA lane and experimental lanes from the ArmAFe(II) mutants. Autoradiography of the gel with Kodak Hyperfilm was typically carried out
overnight at room temperature. However, the length of time required for appropriate
exposure varied for different primers. Cys-less ArmA is considered to be the background
for the other lanes, since the bands appearing in this lane do not correspond to direct
probing. Band intensities are correlated with the distance between the RNA target and the
position of the Fe(II) on ArmA. When probing was initiated from Fe(II)-modified ArmA
proteins (Figure 16) bound to the active 30S subunit, both unique and in some instances
overlapping, cleavage patterns were obtained from three of the six Fe(II)- derivatized
ArmA proteins.
RNA Footprinting Analysis of ArmA Interaction With the 30S Subunit
To identify the site of interaction between ArmA and the 30S subunit, hydroxyl
radical probing initiated from Fe(II) - modified ArmA proteins bound to the E. coli 30S
subunits was performed as described above. For this experiment, different primers were
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used to scan the whole 16S rRNA, but only primers 480, 939, and 1257 showed
reproducible cleavages (Figure 20). The cleavage patterns obtained from different Fe(II) derivatized ArmA proteins show little similarity and are somewhat dispersed throughout
the 16S rRNA with no evidence of clustering at a specific site on 30S subunit. Cleavages
were seen in helices 25 and 34, in the loops of helices 14 and 15, and in the base of helices
24, 25 and 27 (Figure 21). In addition, we observed cleavage sites along helix 44, but the
helix 44 results were not reproducible when the probing was repeated, so the data were
excluded.
When the cleavage data were mapped onto the structure of the three – dimensional
fully mature 30S subunit7, we noticed multiple binding sites dispersed around the modified
nucleotide G1405 (Figure 22A). Some of the cleavages, such as the ones seen in helices 24
and 27, were more than 30 Å away from the modified nucleotide G1405. In addition to
these distal sites, cleavages were detected on the opposite face of the 30S ribosomal
subunit relative to the target nucleotide, close to the binding site of the ribosomal protein
S15 (Figure 22B). However, the most surprising cleavages identified from this experiment
were completely buried inside helix 34 and inaccessible to ArmA in the translationally
active 30S conformation. In addition, we observed cleavage sites along the helix 44 (data
not shown); however, the helix 44 results were not reproducible when the probing was
repeated. It should be noted that these experiments were performed in the absence of SAdenosyl Homocysteine (SAH) as a surrogate second substrate (inhibitor). However, the
presence of this second ‘substrate’ is unlikely to be critical for ArmA binding to the 30S
subunit, since similar ambiguous results were obtained for Sgm footprinting experiments,
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Figure 20. Primer extension analysis of directed hydroxyl radical cleavage of 16S rRNA in
the translatioanally active 30S subunits from Fe(II)-ArmA. Cleavage sites and the
sequence numbers of nucleotides within 16S rRNA are denoted by bars on left and right of
figures, respectively. A and G are sequencing lanes; Fe(II)-ArmA–30S complexes are:
Cys-less, a Fe(II)-BABE treated cysteine-free mutant of ArmA; Fe(II)-Cys43-ArmA;
Fe(II)-Cys59-ArmA; Fe(II)-Cys65-ArmA; Fe(II)-Cys115-ArmA; Fe(II)-Cys190-ArmA;
Fe(II)-Cys234-ArmA. Primers are 480 (A), 939 (B and C) and 1257 (D).
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Figure 21. Directed hydroxyl radical cleavage sites from Fe(II)-ArmA (shown in boxes) on
the secondary structure of 16S rRNA
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Figure 22. Directed hydroxyl radical probing mapped on the30S subunit from ArmA. The
cleavage sites are shown on the three dimensional structure of E.coli 30S structure7 (A)
and include 180o rotation view of the same figure (B). The modified nucleotide G1405 is
circled in red.
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which were done in the presence of 1 mM SAH66. The multiple and dispersed binding sites
seen in the Sgm-30S complex, observed at helices 24, 42,43, and 44, indicate that SAH
does not influence binding of ArmA (or Sgm) to the 30S subunit.
This ambiguous pattern of ArmA interaction with the 30S subunit could be due to
binding at multiple non-specific sites and/or to large conformational changes in the 30S
subunit upon ArmA binding. ArmA is a monomer under the conditions used for these
experiments, which excludes the possibility of extended oligomers modifying at sites
remote from the methylation site61. The data obtained from this experiment correlate well
with the results reported by Husain et al., where chemical footprinting with CMCT
(specific for nucleotides G and U) and DEPC (specific for nucleotide A) were carried out
on E. coli 30S subunits to determine the sites of interaction between 30S and the
sisomicin-gentamicin methyltransferase Sgm, an ArmA homolog66. In contrast to the
ArmA – 30S binding sites, Sgm cleavages extended to helix 44, where the modified
nucleotide G1405 lies. They reported that conformational changes occur in the 30S
subunit, upon its interaction with Sgm, that allow the enzyme to access the target
nucleotide G1405, which is otherwise buried in the crystal structure of 30S subunit66.
To gain insight into possible ArmA and target - base interactions, we tried to build
a model using the program PyMol29. However, we were not able to position G1405 into the
active site of the ArmA – SAM complex due to multiple close contacts. First, we tried to
build the ArmA -30S model using the crystal structure of fully formed translationally
active 30S ribosomal subunit7. In this 30S structure, the modified base was completely
sequestered in the helix 44 and was not accessible to ArmA for transfer of the methyl
group. Second, our directed hydroxyl radical data revealed that ArmA reached mostly the
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solvent – exposed face of helices. This implied that the target base was never closer than
20Å to the methyl group of SAM. Third, even if we minimized the distance between the
methyl group of SAM and the target nucleotide, the base would need to be rotated out of
helix 44 and N7 position of G1405 exposed to the surface. This base flipping mechanism
would be similar to the ones seen in DNA and RNA modifying enzymes that access target
bases that are normally not accessible due to secondary and/or tertiary interactions in the
nucleic acid molecule100. Lastly, the largest limitation in building the model was the
number of dispersed binding sites that we observed in our hydroxyl radical data
experiment, especially the ones found very distal from the modified nucleotide G1405.
Binding of ArmA to 30S and SAM
In spite of the wealth of literature on rRNA methylation, the structural information
currently available for RNA methyltransferases is insufficient to elucidate their mechanism
of action. Even though directed hydroxyl radical data revealed a very weak and multiple
non- specific binding of ArmA to 30S subunit (Figure 22), we were curious to further
explore the binding interactions between ArmA and its substrates. Assuming that the
absence of SAM does not effect the binding of ArmA to 30S subunit, we decided to
determine the affinity of ArmA for each substrate separately. One of the methods used to
study the physical basis of molecular interactions between enzyme and substrates is
isothermal titration calorimetry (ITC). ITC provides a direct way to the complete
thermodynamic characterization of protein interactions. In one ITC experiment we can
physically measure the heat generated or absorbed during a binding reaction (ΔHobs). The
typical experiment involves addition of one binding partner (titrant) to the other binding
partner (titrate) over time using one or more individual injections (Figure 23).
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Figure 23. A schematic diagram of a typical isothermal titration calorimeter.
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Here, heat is measured as the change in power required for maintaining temperature
between the sample and a reference cell. Then, a binding enthalpy is calculated based on
knowledge of the cell volume and the concentration of the reactants. The observed
enthalpy measured in an experiment includes not only the heat of binding between the
molecules, but also any additional heat sources associated with the reaction, including
solvent effects, molecular reorganization and conformational changes, and heats of dilution
resulting from sample stirring. The heat produced during each injection is proportional to
the amount of complex formed, so maximal changes in enthalpy occur at the earliest points
in a titration with a decrease in magnitude as free titrant is consumed. Since all equilibrium
constants vary with temperature, according to van’t Hoffs equation (1), we can calculate
the affinity constant:
d lnK/ dT = ΔH/ RT2

(1)

where R is the gas constant, T is the absolute temperature. An equilibrium constant is also
related to the Gibbs free energy (ΔG) of binding by the reaction (2):
ΔG = - RT ln Ka

(2)

Since the ΔHobs is measured directly from the ITC experiment, we can also calculate the
reaction entropies (ΔS) from the reaction (3):
ΔG = ΔH –TΔS

(3)

The complete thermodynamic characterization can be obtained from a single ITC
experiment, which makes this technique very widely used. With modern ITC
instrumentation, sample requirements are greatly reduced, which makes this method
applicable to study RNA biochemistry, among other systems. One other benefit of using
this method is that it does not require labeling of the protein or substrates, which might
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interfere with ArmA folding or binding to the 30S subunit. Because of its benefits and
simplicity, we decided to implement the ITC technique to determine the binding of ArmA
to its substrate.
First, we titrated ArmA with S- Adenosyl-L-Methionine (SAM). ArmA showed
clear binding to SAM, with an affinity in the low micromolar range, 45.8 ± 0.00147 µM.
The fit for this titration produced reasonable stoichiometry, with N equal to 1.02 ± 0.138,
indicating one SAM molecule bound per protein. The injection profile and the integration
(heat release) for each injection (except the first one) are shown in the figure 24. The solid
dots indicate the experimental data. The best fit to the experimental data, integrated
response versus molar ratio of ligand added, was obtained using a single site fitting model
from Origin 7.0 software (OriginLab Corp). The result was in agreement with a Kd value
of 18 µM obtained for Sgm, ArmA ortholog, binding SAM66,101. In addition, the binding
constant was similar to the Kd value for RsmC, which methylates m2G1207 in 16S rRNA
(Kd 4.8 µM)102. It is important to note that KdSAM is very similar to KmSAM (40 ±15 µM)61,
which indicates that SAM is bound with comparable affinity in the binary complex and in
the presence of 30S subunits.
Our next goal was to determine the dissociation constant for ArmA and 30S
subunit, since it has not been reported. Since ITC has been successfully used for measuring
the binding between the 30S and small molecules103, we assumed that determining the
binding of ArmA to 30S subunit would not be any different. However, the absence of any
previously reported ITC measurements between a protein and a ribosomal subunit
foreshadowed the encountered complications. Only one such (unsuccessful) experiment
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has been reported and that was the attempt to measure the binding of the housekeeping
methyltransferase RsmC, which methylates m2G1207102 , to 30S subunit.
The thermodynamics of ArmA – 30S interactions were measured using the VP –
ITC 200 calorimeter. Mature 30S subunits were placed in the sample cell and ArmA in the
syringe. Both solutions were extensively dialyzed in the same buffer solution containing 40
mM HEPES (pH 7.5), 40 mM NH4Cl, 8 mM Mg acetate, 10% glycerol and 6 mM BME.
The concentration of 30S was varied from 2 µM to 10 µM while the ArmA concentration
was 10 to 20 times higher than the 30S subunit to insure saturation. Assays were attempted
at 20oC or 37oC. The spacing between injections was 300 seconds to insure baseline
equilibration after each ArmA sample addition.
Numerous failed trials to measure the binding of ArmA to 30S ribosomal subunits
prompted the conclusion that ITC for whatever reason is not suited for this task. Figure 25
shows different isothermal titration calorimetric measurements for ArmA and 30S subunit.
From these experiments, we notice that saturation of 30S by ArmA does not occur, even
when an excess of ArmA (twenty times) was used to ensure the completion of the reaction.
Control experiments verified that the large signals observed were not artifacts. In this case,
ArmA was titrated into the buffer (previously described) to ensure that the interaction
between ArmA and the buffer does not compensate the heat change between ArmA and
30S subunit. In this experiment, we noticed a very small change in the heat transfer,
indicating that the ArmA dilution effect was negligible. We also tested the ArmA – ArmA
interaction to ensure that ArmA did not aggregate and cause a large false signal. Once
again, we did not observe a large heat change when ArmA was titrated into ArmA.
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Figure 24. Isothermal titration calorimetric analysis of SAM binding to ArmA. (A)
Titration of SAM (via syringe) into the ArmA protein (sample cell); (B) The binding
isotherm fit to a model of a single SAM binding site.
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Figure 25. Isothermal titration calorimetric analysis of 30S subunit binding to ArmA. A)
Titration of ArmA (via syringe) into the 30S subunits, in ratio 10:1. Figures (A) and (B)
depict two different experiments (from different 30S and ArmA preparations)
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Therefore, the ITC analysis for ArmA/30S binding appears valid, yet cannot be explained
by a simple bimolecular reaction. To ensure the analysis was performed with active ArmA
and 30S subunits, both were tested and confirmed active in a standard in vitro
methyltransferase assay (Figure 26). The 30S subunits were fully methylated in the
presence of ArmA and both the enzyme and the substrate were active when the ITC
experiments were performed. However, it remains a mystery as to why the 30S/ArmA
binding data cannot be simply fit to standard binding models.
To ensure that 30S subunits do not stick to the wall of the sample cell and prevent
binding, we reversed the reaction and titrated the 30S into the ArmA (placed in the cell). In
this experiment, we varied the concentration of ArmA from 2 to 10 µM and the 30S from
15 to 40 µM. The experiment was performed at 37oC to ensure the same conditions would
be followed as for the in vitro activity assay. The spacing between injections was 300
seconds to ensure enough time for equilibration. The first titration was 0.5 µL followed by
fifteen 2.5 µL injections (Figure 27). Results were identical to those seen in Figure 25,
where we did not observe the saturation of ArmA by 30S subunits even when they were in
the vast access.
Finally, the question remains of whether or not SAM is required before ArmA can
bind 30S subunit. Since SAM could not be used in this experiment (methylation would
occur) the product SAH was used, but the data showed the same curve as for the previous
experiments (Figure 28A). In the course of conducting the attempt to measure the binding
reaction, we also measured the thermodynamic contribution of the methyl transfer reaction.
To 30S subunits and SAM placed in the cell, we titrated ArmA and SAM; however, the
analysis revealed nearly identical results to all previous ArmA/30S experiments (Fig. 28B).
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Figure 26. In vitro methyltransferase activity assay of ArmA. Assays were performed in
triplicate; error bars represent standard deviation.
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Figure 27. Isothermal titration calorimetric analysis of ArmA titrated into 30S ribosomal
subunit.
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Figure 28. Isothermal titration calorimetric analysis of 30S binding to ArmA in the
presence of SAH (A) and SAM (B).
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One possible explanation for the results obtained might be that ArmA does not bind
to the 30S subunit very tightly and hence we do not observe the interaction; however, we
observed heat changes during the reaction. Another possibility is that ArmA binds to 30S
at multiple binding sites, which is consistent with the results obtained from the directed
hydroxyl radical probing experiments (Fig 22), thus making it difficult to interpret the
binding using the ITC method.
Fluorescence Polarization Anisotropy
The second method used to determine the Kd of ArmA and 30S subunit was
fluorescence polarization (anisotropy). This method is widely used for measuring the
binding interactions between two molecules, and it can be used to determine the binding
constant (or the dissociation constant) for various interactions. In this technique, a
fluorophore attached to one of the molecules is excited by polarized light. This absorption
of light by a population of molecules induces electron passage from the singlet ground
electronic level S0 to an excited state Sn (n>1). An excited molecule will return to the
ground state via emission of a photon (fluorescence), which is measured with a polarizer as
a polarized light. Fluorescence polarization is defined by the following equation (4):

P = (IV – IH) / (IV + IH)

(4)

where P equals polarization, IV equals the vertical component of the emitted light, and IH
equals the horizontal component of the emitted light of a fluorophore when excited by
vertical plane polarized light. However, if the molecule is moving, the polarization of the
light will be reduced by radiation in a different direction from the incident light (‘scramble’
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effect)104. This effect is greatest with fluorophores freely tumbling in solution and
decreases with decreased rates of tumbling. Upon binding of fluorescently labeled ArmA
to the 30S subunit, tumbling of the fluorophore will reduce, thus increasing the amount of
polarized light detected. The effect should be particularly large given the relative
molecular weight of ArmA (~30,000 D) and the 30S subunit (~900,000 D).
In our experiment, ArmA was fused to fluorescein-5 –maleimide at the sulfhydryl containing cysteine residue. We used the previously described ArmA C115A G234C
double mutant for fluorophore attachment at C234, since this residue was exposed to the
surface and accessible for labeling. By titrating 30S subunits (from 1 to 2,000 nM) into the
50 nM ArmA, attempts were made to measure changes in polarization, which should be
proportional to the amount of ArmA – 30S subunit complex formed. However, we were
unable to detect the binding of ArmA to 30S over the concentrations tested (Figure 29A).
To determine if the presence of SAM was necessary for ArmA – 30S complex formation,
we repeated the experiment in the presence of 1 mM Sinefungin (a natural SAM analog).
As in the ITC experiments, the presence of a SAM surrogate did not affect the outcome
(Figure 29B).
At this point, the question remains open as to the order of substrate addition. Our
ITC and fluorescence anisotropy experiments do not confirm that the binding of SAM to
ArmA is a prerequisite for ArmA – 30S complex formation. The best evidence for that
would be the crystal structure of ArmA in complex with its substrates; however, only two
structures of methyltransferases, RumA and TrmA, in complex with their respective RNA
substrates have been solved105,106. The one unsuccessful attempt to obtain evidence for the
nucleotidic substrate binding site for Arm/Rmt group of enzymes was by soaking the
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Figure 29. Fluorescence anisotropy for ArmA and 30S in the absence (A) and presence of
1 mM Sinefungin.
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RmtB- AdoMet crystals in a solution containing GMP65. However, the structure of RmtB –
GMP complex revealed that the base and ribose binding sites exactly match those observed
for SAM; i.e. the nucleotide G1405 occupies the binding site of the SAM and not the target
guanosine in the 16S rRNA.

Conclusions
We measured the binding constant of ArmA and its substrate, S- Adenosyl- LMethionine by ITC method and found the dissociation constant to be 45.8 µM. We were
unsuccessful in determining the binding constant of ArmA and 30S subunits using two
different methods. It is very possible that the translationally active 30S ribosomal subunits
used in our experiments do not bind very tightly to ArmA; hence, we are not able to detect
the binding using aforementioned methods. However, the same 30S subunits are capable
of being methylated in the presence of ArmA, as shown in our in vitro activity assay. This
implies that the mechanism of action is complex for this group of enzymes. For that reason
we decided to create a minimal kinetic scheme for Arm/Rmt methyltransferases to help us
understand the complexity of this group of enzymes (Figure 30). High Mg+2 concentrations
stabilize an active state of 30S, while low concentrations of Mg+2 stabilize a translationally
inactive conformation of the 30S subunits, represented here as 30S* (k1/k-1 step)69. We
have shown (in Chapter 2) that ArmA, in the presence of SAM, can recognizes both forms
of 30S subunits and transfer the methyl group to the N7 position of G1405 (k5 step). Once
the guanosine nucleotide becomes modified, the product (SAH) is released (k6 step). We
took into consideration a possible conformational change in 16S rRNA upon methylation
of G1405, which could lead to the formation of different conformation of 30S subunit,
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Figure 30. Minimal kinetic scheme of ArmA methylation of 30S subunit. Translationally
inactive 30S subunit is represented as 30S*, possible conformation of methylated 30S
subunit is represented as me30S**.

68

represented here as me30S** (k-11 step). Since rRNA methyltransferases have not been
extensively characterized, one of the experiments to be considered in the future could be to
try and trap a more stable ArmA/30S/SAM complex. This way the methylation step would
be stalled and the complex would be stable enough to measure the rate of binding. This
could be done by having an ArmA mutant which would be catalytically inactive but able to
bind to the 30S subunit.
Directed hydroxyl radical probing experiments revealed that ArmA binds very
weakly to its substrate, 30S ribosomal subunit. At this time, we are unable to build a model
of ArmA – 30S complex that would satisfactorily explain all our footprinting data.
Cleavage sites more distal to G1405, even at the opposite face of the ribosome relative to
the target nucleotide, suggest that ArmA binds 30S subunits weakly, and possibly nonselectively. Hence, conformational changes that are expected to occur in 16S rRNA upon
ArmA binding are most likely complex and involve multiple rearrangements of spatially
distant elements that probably have a global character. Data indicate that the mechanism of
action for the ArmA group of enzymes is complex and has to be studied in detail by
measuring discrete steps of the process. Only when more biochemical data become
available will it be possible to design specific inhibitors to treat infections due to bacteria
resistant to 4,6 - disubstituted aminoglycosides.

Experimental
Mutagenesis
Primers were designed which contained the mutations of interest flanked by 15-20
bases of wild-type sequence (Table 1). Mutagenesis was performed using the Stratagene
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QuikChange Kit according to the manufacturer’s protocol. Briefly, wild-type plasmid was
denatured and the primers were annealed and extended by thermal cycling with PfuTurbo
DNA Polymerase (Stratagene). DpnI (Stratagene) was used to digest the parental (nonmutant), naturally methyalted DNA. The plasmids were then transformed into E. coli XL1Blue cells and ArmA mutants were confirmed by sequencing.
Protein and 30S Subunits Expression and Purification
Proteins and 30S subunits were expressed and purified as described in Chapter 2.
Activity Assay
In vitro activity assay was performed as described in Chapter 2.
Hydroxyl radical probing experiment
Hydroxyl radical probing experiment was performed under the supervision of Dr.
Gloria Culver, as described89.
Preparation of Fe(II)-BABE derivatized ArmA
Fe(II)-BABE complex was formed as previously described by Xu et al. (2008)72.
In brief, 3 nmol ArmA (cysteineless or cysteine-substituted) were incubated with 70 nmol
Fe(II)-BABE in BABE modification buffer (1 M KCl, 80 mM K+-Hepes, pH 7.6, 0.01%
Nikkol) in 100 ul total volume at 37°C for 30 minutes. Excess Fe (II)-BABE was removed
from derivatized ArmA by centrifugation at 5000 rpm in Microcon (10,000D cutoff)
centrifugal concentrators at 4 °C followed by additional washes with 400 µl BABE
modification buffer.
Formation of ArmA/30S subunit complexes
The formation of the ArmA/30S complex was done essentially as described72. In
brief, 30pmols submethylated 30S subunits were incubated with 150 pmols Fe(II)-ArmA
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in buffer containing 40 mM Tris, pH 7.2, 40 mM NH4Cl, 8 mM MgOAc, 1mM DTE in
100 µl total volume at 37 °C for 1 hour. Unbound Fe(II)-ArmA proteins were removed
using Sephacryl S-200 spin columns at 2000 rpm for 3.5 min.
Primer extension analysis
Directed hydroxyl radical probing was done essentially as described by Culver and
Noller89 (2000). Specific ArmA – 30S complexes, 4 µl Fe-EDTA solution, 2 ul 5%
hydrogen peroxide and 2 ul 500 mM ascorbic acid were added in a total volume of 100 ul.
Reactions were performed on ice and quenched by adding 40 µl 0.1 M thiourea. Each
experiment was performed at least three times to insure that data were reproducible.
Extracted 16S rRNA was analyzed by primer extension as previously described by Stern et
al. (1988)107. Cleavage intensities were compared to the intensity of control sequencing
lanes.
Isothermal titration calorimetry
Isothermal titration calorimetry was performed as described66,101. ArmA in 40 mM
HEPES (pH 7.5), 40 mM NH4Cl, 8 mM Mg acetate, 10% glycerol and 6 mM BME was
titrated against SAM solution prepared by dissolving the appropriate amount of SAM in
the same buffer. The ITC experiment was carried out on a VP - ITC 200 calorimeter
(Microcal, LLC) at 20oC using 0.02-0.1 mM protein in the sample cell and 1-2 mM SAM
in the syringe. All samples were degassed and centrifuged prior to use. Measuring the heat
of dilution for the ligand involved a single 0.5 µL injection, followed by either 1.5 µL or
2.5 µL injection volumes of SAM (depending on the number of injections) with 300
seconds spacing between the injections required for the baseline to equilibrate.
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Fluorescence Polarization Anisotropy
ArmA C115A G234C mutant was labeled with Fluorescein 5- Maleimide in the buffer
containing 20 mM sodium phosphate, pH 7.5, and 150 mM NaCl. We added EDTA at a
final concentration of 5 mM to prevent metal-catalyzed formation of disulfide bonds. We
used 25-fold molar excess of Fluorescein 5 –Maleimide over the molar amount of ArmA to
be coupled. The reaction was allowed to proceed for 30 minutes at 30oC. Non-reacted
fluorescein was removed by desalting. The change in polarization was measured by
titrating 30S subunits (from 1 to 2,000 nM) into the 50 nM ArmA, using TECAN
Polarizon.

Table 1. Primers for Active site mutants
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ArmA Methylation of Variant Forms of 30S Ribosome
Subunits and 16S rRNA
LiCl Treated 30S Ribosomal Particles
Introduction
In the presence of high concentrations of monovalent salts, such as CsCl, LiCl, or
NH4Cl, the ribosomal proteins dissociate from the 30S subunit producing a series of
protein deficient ribosomal particles with different sedimentation coefficients108. This
dissociation is primarily the result of a weaker association of proteins on the RNA scaffold
due to the suppression of their electrostatic interactions in the presence of higher ionic
strength. Both during incubation at a high salt concentration and with stepwise increase in
ionic strength, groups of proteins sequentially dissociate from the particles, resulting in the
formation of a series of protein-deficient derivatives108,109. In the presence of 1M LiCl,
protein-depleted particles sediment as 25S, while higher LiCl concentrations (1.5, 2.0. 3.0
or 3.5 M) produce particles that sediment as 23S, 21S, 19S and 16S, respectively108. The
stepwise dissociation of ribosomal proteins from E. coli 30S subunit with increasing LiCl
or CsCl concentration is schematically shown in Figure 31. Initially, at low salt
concentration, loosely bound proteins dissociate first, followed by the more strongly bound
core proteins. The order of protein dissociation by LiCl or CsCl roughly reflects the order
of their assembly into the 30S subunit13,14 (Figure 32).
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Figure 31.Scheme of the disassembly of the 30S ribosomal subunit achieved by high
concentration of LiCl108.
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Figure 32. In vitro assembly map of the 30S subunit. 16S is shown on the top. Arrows
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proteins are colored black, red and green, respectively. The S6 and S18 bind as a
heterodimer13,14.
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Results
ArmA recognizes and methylates mature 30S ribosomal subunits, but not phenolchloroform extracted 16S rRNA61. The question remains as to what the minimal number of
ribosomal proteins required for ArmA methylation in vitro is. In an attempt to answer this
question, 30S ribosomal subunits were prepared by incubation with increased
concentration of LiCl using the procedure of Itoh et al (1968)108. The protein depleted
particles were isolated using sucrose gradient sedimentation and measured for their methyl
acceptor activity. We found that treatment of mature 30S subunits with even low
concentrations of LiCl (up to 0.75M) led to a sharp decrease in susceptibility to
methylation (Figure 33A). The 30S subunits treated with 1M LiCl showed a very low level
of methyl acceptor activity, while no activity was seen for subunits treated with higher
concentrations of LiCl. The decrease in ArmA activity is attributed to ribosomal protein
loss, since a 2% agarose gel containing formaldehyde confirmed that 16S rRNA was not
degraded during preparation of subunits at any of the LiCl concentrations used (Figure
33B).
We further analyzed subunits treated at low concentrations of LiCl (0 to 1M) for
changes in the composition of their associated proteins (Figure 34). Since the ArmA
activity decreased slightly in the presence of 0.5M LiCl, we sought to identify the
ribosomal protein(s) dissociated in this range of LiCl concentration, which are likely to be
required for the full activity of ArmA. Qualitative two dimensional acrylamide gel
electrophoresis revealed that at low LiCl concentrations (up to 1 M), treated subunits retain
the same complement of ribosomal proteins as the LiCl untreated sample, even though
their susceptibility to methylation by ArmA drops significantly (Figure 33A).
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Figure 33. In vitro methylation of LiCl-treated 30S ribosomal subunits (A). A 2% agarose gel
containing formaldehyde, confirming that 16S rRNA is not degraded (B)
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Figure 34. Two dimensional acrylamide gels showing ribosomal proteins isolated from the
LiCl treated particles.
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It is important to note that the ribosomal protein S6 was not measured in this 2D gel
system, because of its acidic PI110. However, from Figure 31, we note that the ribosomal
protein S6 is expected to come off in the higher LiCl concentration and would not
influence the decrease in ArmA activity when lower concentrations of LiCl treated
particles were used. Even subunits treated with 1 M LiCl, where methylation activity is
almost completely abolished, show no significant subtraction of any of the 30S proteins.
Although this experiment provides only a qualitative assessment of the protein
complement of LiCl treated 30S subunits, the sharp difference in ArmA activity between
0.5 M LiCl and 0.75 M LiCl particles (Figure 33A) in the absence of any detectable
difference in protein content (Figure 34) argues against a role for the proteins in the
observed loss of ArmA activity.
The dissociation of most of the proteins from the ribosomal particles does not
appear to disrupt the overall tertiary structure and compactness of the RNA111,112. Electron
microscopy experiments reveal that removing half of the proteins does not lead to
significant morphological changes in the particles. When a fragment of the 16S rRNA
(corresponding to the central domain) and five proteins S6, S8, S11, S15 and S18 was
examined by electron microscopy, the isolated particles had an appearance that was similar
in size and shape to the corresponding morphological features of the 30S subunit111. In
contrast, our experiments imply that the decrease in ArmA activity is likely due to changes
induced by the LiCl in the 16S rRNA. Structural support for the possibility of a significant
conformation change in the helix 44/45 region comes from cryo-EM studies of the
complex RbfA with 30S ribosomal subunits113,114. To further test our observation, the 30S
subunits treated with varying concentrations of LiCl were incubated in high Mg2+ buffer
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with 50S subunits and showed a progressive decline in the yield of 70S with increasing
concentration of LiCl used to treat the 30S subunits (Figure 35). This result, taken with
the activity assays for the LiCl treated subunits (Figure 33A), indicates that even at low
concentrations of LiCl, only a fraction of the particles are in a conformation that can
function as an ArmA substrate.
Pre-30S Ribosomal Particles as ArmA Substrates
The 16S rRNA undergoes covalent modification, primarily methylation, at a
number of sites during maturation of the 30S ribosome subunit. For the methyltransferase
RsmB, protein-depleted 16S rRNA can serve as an in vitro substrate32. A larger number
of methyltransferases, e.g. RsmC, RrmJ, KsgA (RsmA)31, RsmF74, RsmH, and RsmI75
require a more complex substrate than the naked 16S rRNA for methylation to occur. In
the E. coli 30S7 ribosomal subunit crystal structure, many of the nucleotides that are
methylated are clearly not accessible to modification enzymes, including those for which
the mature 30S subunit serves as a substrate78. Some of these may be modified in vivo
during the maturation process when subunit intermediates offer functional substrates to the
modifying enzymes76. Others may reflect inherent lability in parts of the 30S subunit that
permits transient access to sites that are otherwise sequestered in the most stable form of
the assembly. The region of the 16S rRNA with the highest density of nucleotide
methylation targets is around the mRNA decoding site, which is known to be structurally
dynamic77.
It has been shown that the modification at m5C1407 by the housekeeping
methyltransferase RsmF is impeded as Sgm, an ArmA homolog, gains access to the
nucleotide G140573. In contrast, the two methylations at nucleotide m5Cm1402
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Figure 35. Sucrose gradient for 30S LiCl-treated subunits assembled with 50S ribosomal
subunits into 70S ribosome. 30S subunit treated with (A) 0M LiCl, (B) 0.5M LiCl, (C)
0.75M LiCl, (D) 1M LiCl assembled into 70S by incubation with 50S ribosomal subunits.
Peak number one corresponds to 30S ribosomal subunit; peak number two corresponds to
50S ribosomal subunit; peak number three corresponds to 70S ribosome.
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(RmsH and RsmI) are unaffected by the presence of Sgm, indicating a requirement for
local changes in the structure of the 30S subunit when these modification enzymes bind to
and modify mature 30S subunits, together with a specific order for methylations of
nucleotides in 30S subunits73.
We tested pre-30S subunits, which do not assemble into 70S ribosomes, as
potential ArmA substrates. The pre-30S subunit sediments as fully formed 30S and
contains 17S rRNA, a precursor of 16S rRNA, which is the product of the RNAse III
cleavage that separates small subunit rRNA from the remainder of the primary
transcript1(Figure 36). Further processing of 17S rRNA by RNAses E, G, and a still
uncharacterized RNase produce the mature 5' and 3'ends1. Small GTPases Era26 and
RsgA27 as well as RbfA, RimM28, and RimN1 proteins are required for proper processing
of the pre-16S rRNA. The absence of these proteins may impair 17S processing by
interfering with 30S assembly and accumulating pre-30S subunits. However,
characterization of pre-30S subunits remains incomplete. It is still an open question which
ribosomal proteins, housekeeping methyltransferases, and ribosomal binding factors are
present in the pre-30S subunits. However, it has been determined that the loss of
methyltransferase KsgA alters 16S rRNA processing and accumulation of pre-30S
subunits76. Even though it has been determined that ArmA recognizes fully formed 30S 61,
we were interested in investigating if the pre-30S ribosomal particles could serve as a
substrate.
Fully formed 30S ribosomal subunits were separated from the pre-30S subunits on
a sucrose gradient following the procedure of Connolly et al. (2008)76. For this experiment
we used Keio collection cells in which ksgA was deleted (E.coli strain JW0050-3)115 to
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avoid possible inhibitory effects of bound KsgA on ArmA76 (see below and Connolly et al.
(2008)). The pre-30S subunits were measured for methyl acceptor activity by 3H
incorporation from 3H- SAM (Fig. 37) relative to a control of fully formed 30S ribosomal
subunits prepared from 70S ribosomes isolated from the same ∆ksgA strain. Our results
show that pre-30S subunits are sub-optimal substrates for ArmA in vivo.
Our data imply that the optimal substrate for ArmA in vivo is structurally
significantly different from the pre-30S subunit. This outcome is not very surprising if we
take into consideration that even a small change in 16S rRNA conformation affects ArmA
activity and that an almost fully formed 30S subunit is required for the enzyme to transfer
a methyl group to G1405.

Conclusions
To determine whether limited depletion of proteins from the 30S subunit affects
ArmA methylation activity, we prepared 30S ribosomal subunits by incubation with
increasing concentrations of LiCl, using the procedure of Itoh et al. (1968)108. We found
that treatment of mature 30S subunits with even low concentrations of LiCl (up to 0.75M)
led to a sharp decrease in susceptibility to methylation. The 30S subunits treated with 1M
LiCl and sedimenting at 25S108 showed a very low level of methyl acceptor activity, while
no activity was seen for subunits treated with higher concentrations of LiCl (Figure 33A).
This experiment implies that the decrease in ArmA activity is due to changes induced by
the LiCl in the 16S rRNA. This is supported by the observation that 30S subunits treated
with varying concentrations of LiCl when incubated in high Mg2+ buffer with 50S subunits
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Figure 37. In vitro methylation of pre-30S subunits and 30S subunits from 70S ribosomes
at 37סC and 25סC as ArmA substrates.
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showed a progressive decline in the yield of 70S with increasing concentration of LiCl
used to treat the 30S subunits (Figure 35). This result taken with the activity assays for
the LiCl treated subunits indicates that even at low concentrations of LiCl, only a fraction
of the particles are in a conformation that can function as an ArmA substrate.
We also tested whether ArmA can methylate pre-30S subunits, which do not assemble
into 70S ribosome. Our results show that these pre-30S subunits are sub-optimal substrates

for ArmA in vivo. We conclude that ArmA requires a highly structured ribonucleoprotein
particle as a substrate for methylation, and the methylation event in the 3' minor domain of
16S rRNA occurs late during 30S ribosome assembly.
Experimental
Protein and 30S Subunits Expression and Purification
Proteins and 30S subunits were expressed and purified as described in Chapter 2.
Activity Assay
In vitro activity assay was performed as described in Chapter 2.
LiCl salt washes of 30S subunits
Protein-depleted 30S ribosomal subunits were obtained by treatment with
increasing concentrations of LiCl according to Itoh et al. (1968)108. Briefly, 30S subunits
were diluted into buffer (20 mM Tris-HCl, pH 7.8, 100 mM Mg(OAc)2 and 1 mM DTE) at
final LiCl concentrations of 0M, 0.5M, 0.75M, 1M, 1.25M, 1.5M, 1.75M, or 2M. Samples
with concentrations of LiCl higher than 1M were incubated overnight at 4°C; others were
prepared just prior to centrifugation. LiCl-washed particles were pelleted by centrifugation
at 45,000 rpm in a Beckmann 70Ti rotor for 6.5h and a sucrose sedimentation profile was
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performed as described (Basturea et al, 2007)67. Pellets were re-suspended in buffer
containing 20 mM Tris-HCl, pH 7.8, 0.1 mM Mg(OAc)2, 1 mM DTE and isolated on a 1030% sucrose gradient by centrifugation in a Beckmann SW28 rotor at 25,000 rpm for 17
hours. Peak fractions were collected, concentrated by centrifugation through an Amicon
Ultra 30K cutoff filter, and stored at -80oC.
Two-dimensional Analysis of 30S and 30S-like Subunits
The peak containing LiCl-treated RNA-protein complex was also examined on 2D
gels, following a protocol derived from Geyl et al (1981)116 and modified by Lyon and
Culver (unpublished data). In brief, LiCl treated subunits were isolated and precipitated
using sodium acetate and ethanol. The samples were incubated at -20oC overnight and
centrifuged at 10000 RPM for 30 minutes at 4oC. Pellets were then re-suspended in 50µl
deionized H2O. Mg-acetate/acetic acid was added to the mixture and centrifuged at 10000
RPM for 30 minutes at 4oC. To the supernatant, 5 volumes of acetone were added, the
samples vortexed and precipitated at -20oC, centrifuged at 10000 RPM for 30 minutes and
the pellets resuspended in deionized H2O. Samples were run on 2D gels (Biorad) and
ribosomal proteins were stained using SYPRO Ruby protein gel stain (Biorad).
Assembly of 70S from 30S LiCl-treated subunits and 50S ribosomal subunits was
performed as follows: 30 pmols of 30S subunits (MRE600) from different LiCl treated
concentrations (0M, 0.5M, 0.75M, and 1.0M LiCl) were incubated with 60 pmols of 50S
ribosomal subunits (MRE600) at 37 oC for 1 hour in buffer containing 40mM Tris-HCl, pH
7.5, 10 mM MgCl2, 100 mM NH4Cl, and 1 mM DTE. Samples were loaded onto a 1040% sucrose gradient in a buffer containing 40mM Tris-HCl, pH 7.5, 10 mM MgCl2, 100
mM NH4Cl, and 1 mM DTE and spun in an SW28 rotor at 19,000 rpm for 17 hours.
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Competitors for ArmA Binding and Methylation of 30S subunits
The structural basis of aminoglycoside binding to the ribosomal A site has been
studied by X-ray crystallography and NMR40,45. The NMR studies, showing the interaction
between the aminoglycoside gentamicin and 27 nucleotides that correspond to the E.coli
16S rRNA in the region of the A site (Figure 38A), highlighted the hydrogen bond
between residue G1405 and the antibiotic. In addition, the crystal structure of an RNA
fragment containing the A site (Figure 38B) bound to 4,6- disubstituted aminoglycoside
geneticin reveals the detailed interaction between the A site and the antibiotic37 (Figure
27C). Results obtained from these studies offer new insights for aminoglycoside - A site
complexes. For our studies, it was of particular interest to note that methylation by ArmA
will disrupt the hydrogen bond between N7 of G1405 and the 3' amino group of 4,6deoxystreptamine aminoglycosides and presumably cause steric hindrance between G1405
and ring III of geneticin (Figure 38C). The methylation would also introduce a positive
charge on the modified nucleotide, disfavoring the binding of the 4,6- disubstituted
aminoglycosides, but not the 4,5- disubstituted group of aminoglucosides, to the decoding
site.
It has been observed that translationally active 30S ribosomal subunits are unable
to bind 4,6-disubstituted aminoglycoside gentamicin as a result of G1405 methylation61.
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Figure 38. The contacts between the A site and gentamicin. (A) The secondary structure of
an oligonucleotide that corresponds to E. coli 16S rRNA in the region of the A site. The
natural sequence is boxed in red; the ArmA modified nucleotide G1405 is shown in red45.
(B) Secondary structure of the crystallized RNA fragment40. The two A sites are boxed in
red. (C) The contacts between G1405 and 4,6 disubstituted aminoglycoside gentamicin
(represented in pink). Hydrogen bonds are shown as dashed black lines.
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Since we have shown that ArmA was able to methylate both translationally active and
inactive 30S subunits (Chapter 2), we decided to further investigate if the structural
changes between the two forms of 30S would extend to the gentamicin binding site. So,
30S subunits were pre-incubated with various concentrations of gentamicin (0.01 mM, 0.1
mM, and 1 mM) in both high [Mg+2] (8 mM) and low [Mg+2] (4 mM) reaction buffers.
After the incubation time, ArmA was added to the solution and in vitro ArmA activity
assay was measured (Figure 39). The results demonstrate that the presence of gentamicin,
even at 0.01 mM, inhibits ArmA activity at both [Mg+2] concentrations. The antibiotic
appears to bind to the low [Mg+2] form slightly better than to the high [Mg+2] form (Figure
39), since we observe a greater decrease in ArmA activity at lower concentration of
gentamicin in the presence of low [Mg+2].
The results were not surprising considering that the inactive 30S conformation (low
Mg+2) involves structural rearrangement of the 16S rRNA, where some nucleotides
become more and some less surface exposed69. Changes in reactivity toward probes that
were used to monitor the accessibility of pyrimidines at N3 and purines at N-1 and N-7
position in the active and inactive forms of 30S ribosomal subunits have been observed,
mostly in the ‘decoding’ A- site at positions 1400 and 150069. In particular, G1494 and
U1495 (which are directly involved in gentamicin binding) are more exposed in the
inactive conformation of 30S subunits, making them more accessible to the antibiotic. It is
also possible that the A site by becoming less rigid in the inactive conformation, allows for
easier conformational accommodation upon antibiotic binding. Subsequent direct binding
experiments could be performed to test these observations.
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Figure 39. Effect of gentamicin on ArmA activity. In vitro methylation of wild-type 30S in
the presence of low (4 mM) or high (8 mM) Mg+2
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KsgA Effect on ArmA Activity
Kasugamycin resistance methyltransferase (KsgA) binds to the 30S ribosomal
subunit in the decoding site and along helix 44, even though its sites for methylation (two
adjacent adenosines 1518 and 1519) are located in helix 4572. Since the ArmA modified
nucleotide G1405 lies in helix 44 and makes tertiary interactions with A1518, interference
and mutual exclusivity of these two enzymes in binding at their target sites would be
predicted. Our hydroxyl radical data suggested that some of the binding sites might be
close to the KsgA binding sites on the 30S subunit (Figure 22).
For these reasons, we tested whether KsgA inhibits ArmA methylation as a
possible indicator of where ArmA binds to the 30S ribosomal subunit. Since KsgA
recognizes only the translationally inactive conformation of 30S ribosomal subunit68,
caution needed to be taken when designing the experiment. First, we measured ArmA
methylation activity in the presence of KsgA at low (4mM) Mg+2 concentration, which
stabilizes the translationally inactive conformation of 30S. To ensure that the transfer of
methyl group measured in our assay was due to ArmA activity and not KsgA, we used
catalytically inactive histidine-tagged KsgA (E66A)117,118 and 30S subunits prepared from
the ksgR strain described above. The ksgR 30S subunits were pre-incubated with KsgA
(E66A) for 10 minutes at 37oC prior to adding ArmA and 3H-methyl group incorporation
from labeled SAM was measured at intervals over a 2 hour period (Figure 40). Our data
show that in the presence of equimolar KsgA, methylation of translationally inactive (low
[Mg+2]) 30S subunits by ArmA was reduced by 25%. Furthermore, in 10-fold excess
KsgA, ArmA methylation activity was completely abolished.
92

Figure 40. In vitro methylation of 30S. (A)Time course competition assays of ArmA with
KsgA E66A. Triangles indicate assays containing 10 pmol 30S ksgR 30S and 10 pmols of
ArmA; diamonds indicate assays containing 10 pmol 30S ksgR 30S, 10 pmols of ArmA,
and 10 pmols of KsgA E66A; squares indicate assays containing 10 pmol 30S ksgR 30S,
10 pmols of ArmA, and 100 pmols of KsgA E66A; crosses indicate assays containing 10
pmol 30S ksgR 30S and 10 pmols of KsgA E66A.
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These results correlate well with our prediction that ArmA and KsgA share the same
binding site, or at least that their binding sites overlap to some extent. The conclusions of
this experiment are qualified by the fact that the lower final counts seen in this in vitro
assay might be due to the fact that the translationally inactive 30S subunits lacking the
methylation at A1518 and A1519 used in this experiment are not the optimal substrate for
ArmA.

IF-3 effect on ArmA Activity
Initiation factor 3 (IF3) and KsgA compete for binding to the 30S subunit62. Since
KsgA and ArmA compete for the same site on the 30S subunit (Figure 40), we extended
our competition experiments to determine whether the binding sites of IF3 and ArmA also
overlap. We purified histidine-tagged IF3 and used it as a competitor in methylation assays
for ArmA activity. Wild type 30S subunits (10 pmols) were incubated with 10 pmols of
IF3 in buffer containing 10 mM Mg2+ for 10 minutes prior to addition of ArmA (Figure
41). Our results show that IF3 did not have an inhibitory effect on methylation by ArmA,
when compared to the control experiment where IF3 was not present in the reaction.
Therefore, we conclude that the common locus for IF3 and KsgA binding does not
intersect that for ArmA72,93. Indeed, our hydroxyl radical probing experiment (as well as
the footprinting results for Sgm)66 did not show any cleavage sites at the 790 stem – loop,
the most likely site shared by IF-3 and KsgA72,93. To ensure that the complex between IF3
and 30S ribosomal subunit was formed, we used the same condition as for the in vitro
activity assay and separated the complex using 10-30% sucrose gradient, which was
checked on SDS PAGE gel for the presence of IF-3 (data not shown).
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Figure 41. In vitro methylation of 30S. Time course competition assays of ArmA with IF3. Diamonds indicate assays containing 10 pmol 30S wild type and 10 pmols of ArmA;
squares indicate assays containing 10 pmol 30S wild type, 10 pmols of ArmA, and 10
pmols of IF-3.

.
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In vivo analysis
Arm/Rmt activity is insensitive to the methylation status of A1518 and A1519 in
vitro (Chapter 2), but it is possible that in vivo, where KsgA has a broader role in ribosome
biogenesis beyond that of its methyltransferase function, it could affect Arm/Rmt
methylation76. To test for possible other effects of KsgA in vivo, we measured and
compared MIC values of the antibiotic gentamicin in wild type and ΔksgA strains of E. coli
in the presence and absence of RmtA, which was expressed under the control of an
arabinose-inducible promoter (Table 2). (The pBAD plasmid containing the RmtA was
kindly provided to us by Matthew Baker). RmtA was overexpressed in the presence of 100
µg/ml ampicillin, 64 µg/ml gentamicin, and either low (0.05%) or high (0.2%) arabinose.
If there were no dependence of Arm/Rmt functions on KsgA in vivo, identical MIC values
should be seen for the two strains. A lower MIC in the ΔksgA strain, which corresponds to
decreased gentamicin resistance, could be due to a partial dependence of RmtA activity on
KsgA activity. We found a lower gentamicin MIC for the ΔksgA host under both low and
high levels of RmtA (0.05% and 0.2% arabinose concentrations used to modulate RmtA
expression). In 0.05% arabinose the ΔksgA strain was more sensitive to gentamicin, with
an MIC value of 32 μg/ml versus 256 μg/ml for wild type; similarly in 0.2% arabinose at
higher RmtA concentrations the MICs for ΔksgA and wild type were 256μg/ml and
512μg/ml.
However, this observation cannot be ascribed to a direct interplay between KsgA
and RmtA, since the control experiment done in the presence of arabinose and the absence
of plasmid borne RmtA gave an MIC of 32 μg/ml for the wild type strain and 8 μg/ml in
the ΔksgA strain. Therefore, we conclude that there is probably no functional dependence
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Table 2. In vivo activity assay
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of RmtA on KsgA in vivo under the conditions examined here and that ΔksgA has an
inherent increased gentamicin sensitivity arising from other causes.
To further explore the difference in sensitivity between the wild type and ΔksgA
strains toward various groups of aminoglycosides, we tested the Keio cells in the absence
of RmtA (Table 3). We noticed increased sensitivity toward the 4,6 disubstituted
aminoglycosides (tobramycin and amikacin),but decreased sensitivity toward the 4,5 type
of aminoglycosides (neomycin and paromomycin). As expected, we did not see a
difference in sensitivity between the two strains when streptomycin was used, since this
antibiotic has a completely different structure and binding mode34.
To test whether RmtA can overcome the higher gentamicin sensitivity of the
ΔksgA mutant, we did serial dilutions of E. coli carrying the RmtA plasmid and monitored
cell growth for wild type and ΔksgA strains in the presence of 64 µg/ml of gentamicin
(Figure 42). At high RmtA (0.2% arabinose), the two strains showed only slight difference
in gentamicin sensitivity. However, at low RmtA (0.05% arabinose) we observed a
pronounced growth defect in the ΔksgA strain compared to the parental strain. From our
experiments, we conclude that RmtA can overcome the inherent increased gentamicin
sensitivity in the ΔksgA strain, but only at high levels. Our in vivo studies show that ArmA
likely has a relatively narrow temporal window on the ribosome maturation pathway, but a
wider window of conformational conditions in which to transfer the methyl group to
G1405.
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Table 3. MIC towards different aminoglycoside in Keio cells.
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Figure 42. Overexpression of RmtA in the wild-type and ΔksgA Keio cells. Plating
experiment of saturated culture diluted in ten-fold increments and plated on LB plates
containing 100 µg/ml ampicillin, 64 µg/ml gentamicin, and either 0.2% or 0.05% arabinose
at 37o C.
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Conclusions
We have shown that the differences between active and inactive 30S ribosomal
subunit states do not affect ArmA access to G1405 (Chapter 2). This finding was further
reinforced by the abolition of ArmA activity in the presence of gentamicin at both high and
low [Mg+2]. The result obtained here also implies that the gentamicin binding site, in
which G1405 lies, is not greatly affected in either low or high Mg+2 30S forms. We also
observed a slightly greater decrease in ArmA activity at lower concentration of gentamicin
in the presence of low [Mg+2], indicating that some very subtle changes in the 30S subunit
(between the active and inactive forms) can affect association of the antibiotic with the A
site.
We also showed inhibition of ArmA methylation by pre-bound KsgA at low
[Mg+2], which indicates overlap of the binding sites of KsgA and ArmA. However, this
conclusion is qualified by the requirement for some conformational change in 30S subunit
for ArmA to access G1405. The conformational excursion for binding both KsgA and
ArmA may be the same and each enzyme could be binding to a part of the 16S rRNA
which is not accessible in the static, crystallographically determined 30S subunit structure.
A similar case is found in the sisomicin-gentamicin resistance methyltransferase Sgm, an
ortholog of ArmA, which methylates G1405 in the A site and requires conformational
change in order to access the buried target nucleotide66.
In contrast, the presence of IF3 did not affect the binding of ArmA to the 30S
subunit, indicating that the binding sites for ArmA and IF3 do not overlap. Furthermore,
we can conclude that the common locus for IF3 and KsgA binding does not intersect that
for ArmA.
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Experimental

Proteins and 30S Subunit Expression and Purification
Proteins and 30S subunits were expressed and purified as described in Chapter 2.
pBAD/RmtA construct was kindly provided by Matthew Baker.
Expression and purification of mutant E. coli KsgA and IF3
The pET25b-KsgA and pET28b-IF3 constructs were kindly provided by Dr.
Heather O’Farrell and Dr. Matthew Hartman of VCU and were confirmed by sequencing.
Proteins were expressed in BL21 (DE3) cells (Stratagene) grown at 37°C to an OD600 of
0.6 in the presence of ampicillin (for KsgAE66A) or kanamycin (for IF3). Protein
expression was induced with 0.1 mM IPTG and the cultures grown for a further 4 h. Cells
were harvested and broken as for ArmA and KsgAE66A was purified on a HiTrap Ni+2
chelated column equilibrated with 50 mM NaPO4, pH 8.0, 300 mM NaCl, 10 mM
imidazole. KsgAE66A was eluted with the same buffer containing 250 mM imidazole. IF3 was purified as previously described119. Cells were lysed in 20 mM Tris- HCl, pH 7.7,
60 mM NH4Cl, 10 mM MgCl2, 10% Glycerol, 5 mM BME, 0.1 mM PMSF and 0.1 mM
benzamidine and the cleared lysate loaded onto a HiTrap Ni+2 column. IF-3 was eluted
with 20mM Tris-HCl, pH 7.7, 10 mM MgCl2, 10% Glycerol, 5 mM BME, 0.1 mM PMSF,
0.5 mM EDTA, and 0.3M imidazole. All proteins were estimated to be >95% pure by
SDS-PAGE analysis.
In vitro Activity Assay
In vitro activity assay was performed as described in Chapter 2.
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In vivo analysis
Keio wild type and ΔksgA cells were grown in LB media and ampicillin (100
µg/ml) at 37o C overnight. Saturated cultures were inoculated in LB media in presence of
either low (0.05 %) or high (0.2 %) arabinose and ampicillin (100 µg/ml) until they
reached OD550 of 0.7-0.8. Cultures were diluted in tenfold increments and 5 µl was spotted
on LB plates containing 100 µg/ml ampicillin, 64 µg/ml gentamicin, and 0.05% (or 0.2 %)
arabinose. Plates were incubated at 37o C overnight.
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Conclusions and Future Work
The outlines of E .coli ribosome biogenesis were elaborated by Nomura and
Nierhaus 13, 120, but new levels of complexity have been recognized in the overall
process in recent years76, particularly since the determination of high resolution crystal
structures of the ribosome and its subunits and complexes40,45. Transcription and
processing of pre-16S rRNA is coordinated with association of both ribosomal and
transiently bound proteins, including RNA modification enzymes. While the overall
pathway leading to assembly of the mature ribosome is regulated and clearly ordered,
there is evidence for parallel sequences of steps that converge downstream in the
process1,121.
Bacterial resistance to 4,6-type aminoglycoside antibiotics, which target the
small ribosomal 30S subunit, has been traced to the arm/rmt family of rRNA
methyltransferases isolated from various pathogens. These plasmid-encoded enzymes
transfer a methyl group from S-adenosyl-L-methionine to N7 of the buried G1405 in
the aminoglycoside binding site of 16S rRNA in the 30S ribosomal subunit. We have
characterized aminoglycoside resistance methyltransferase (armA), and obtained
significant information regarding its mode of action. ArmA methylates mature 30S
subunits but not 16S rRNA, 50S or 70S ribosomal particles or isolated Helix 44 of the
30S subunit61. To further explore this family of enzymes, we have investigated the
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substrate requirements of ArmA. We determined the Mg2+ dependence and found that
ArmA could recognize both translationally active and translationally inactive 30S
ribosomal subunits.
We tested the effects of kasugamycin resistance methyltransferase (KsgA) and
initiation factor 3 (IF3) binding to 30S subunits on ArmA activity. The inhibition of
ArmA methylation by pre-bound KsgA at low [Mg+2] indicates overlap of the binding
sites of KsgA and ArmA. However, this conclusion is qualified by the requirement for
some conformational change in 30S subunit for ArmA to access G1405. In contrast,
IF3 showed no effect on methylation by ArmA, from which we concluded that the
common locus for IF3 and KsgA binding does not intersect that for ArmA72. We also
tested LiCl treated 30S particles and in vivo derived pre-30S ribosomal subunits as
ArmA methylation substrates. From these experiments, we conclude that ArmA is most
active toward 30S ribosomal subunits that are at or very near full maturation.
However, additional biochemical studies have to be performed in order to fully
understand this group of enzymes. Mutations of active site residues would be the first
step to explore. This would elucidate the role of residues important for SAM binding
and for target guanosine binding. The binding studies could be performed using the
ITC method for SAM binding, since we were able to measure the binding of wild-type
ArmA and SAM using this technique. Once we identify mutant(s) which are able to
bind 30S subunits but are not catalytically active, we could repeat the binding studies
for ArmA and 30S subunits. This would help us better understand the complex ArmA
mechanism and complete the binding studies for each substrate. Another outstanding
question we would like to address involves the order (if any) of substrate binding. It
would be of interest to know if the binding of one substrate requires a conformational
change of 30S subunits that creates the binding site for the second substrate. These
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studies would involve crystallizing ArmA (or its homologs) with both substrates, 30S
subunit and SAM. It should be noted that only two structures of methyltransferases in
complex with their respective RNA substrates have been determined105,106. Strenuous
efforts are therefore required to perform structural studies of ArmA binding to the A
site of 30S ribosomal subunits. In addition, it would be interesting to further explore
the assembly state of pre-30S ribosomal subunits required for efficient methylation by
ArmA. For those experiments, we could use well established in vitro reconstitution
assays and in vivo gene knock-out assays to define the structural and assembly state
requirements of 30S subunits for ArmA.
All of the aforementioned studies would help us achieve a long term goal – to
develop Arm/Rmt specific inhibitors that will not interfere with other physiologically
important m7G methylations122,123. Since other m7G methyltransferases123 have a
different mode of protein-ligand interaction from that of ArmA, the design of inhibitors
against the medically important ArmA family of methyltransferases is somewhat
simplified. Domains specific for this family of methyltransferases could be considered
as targets for particular inhibitors.
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